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ABSTRACT 
CIGARETTE SMOKE, DNA DAMAGE AND REPAIR IN HUMAN 
CERVICAL AND VAGINAL CELLS IN VITRO AND EX VIVO 
Afsoon Moktar 
September 17, 2010 
Among gynecological malignancies, carcinoma of the cervix is the 
leading cancer type worldwide. Conversely, vaginal tumors account for an 
incidence of approximately 1-2% of lower genital tract malignancies. 
Interestingly, the major shared risk factor among women with cervical and 
vaginal tumors is infection with cancer-associated human 
papillomaviruses (HPVs). In fact, HPV infection is the necessary causative 
factor in the development and progression of cervical and vaginal 
neoplasia in the majority of cases. Epidemiological studies support that 
cervical and vaginal pre-cancerous lesions that are initiated by HPV 
infection generally regress in the absence of known risk factors such as 
cigarette smoking. Further, female smokers have two times higher risk of 
developing cervical cancer from premalignant lesions than non-smokers, 
although the association between cigarette smoking and vaginal tumors 
has been controversial. Cigarette smoking exerts its cytogenetic effects in 
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various forms such as DNA strand breaks and oxidative DNA damage. 
However, previous studies on cervical and vaginal abnormalities failed to 
investigate the effects of cigarette smoking on cervical and vaginal cells 
from a biological standpoint. 
Therefore, the goal of this work was to investigate cigarette smoke-
induced DNA strand breaks, oxidative damage and DNA repair in human 
cervical cancer cells (in vitro studies, Chapters II and III); we also 
examined DNA strand breaks in human vaginal cells in light of cigarette 
smoking and HPV status (an ex vivo study, Chapter IV). It was determined 
that cigarette smoke induces both DNA single- (SSBs) and double-strand 
breaks (DSBs) that are highly persistent, in addition to oxidative DNA 
damage, which is more pronounced in HPV infected human cervical 
cancer cells. Though, CSC-induced oxidative DNA damage was 
eventually removed in the cells, the possibility of error-prone DNA repair, 
however, cannot be ruled out. Lastly, our data derived from the ex-vivo 
study clearly showed an inverse relationship between the interaction of 
cigarette smoking and HPV infection in the induction of DNA strand breaks 
in vaginal cells of the studied population, regardless of age. Further, we 
have clearly showed that the extent of DNA DSBs increases as a function 
of age, which corroborates with the fact that vaginal cancers occur at a 
much older age, as compared to cervical cancers. In summary, the 
findings of this research project shed light on the role of cigarette smoke in 
cervical/vaginal carcinogenesis. Moreover, comet assay might serve as an 
Vll 
early biomarker in identifying susceptible populations that are at risk for 
developing cervical/vaginal abnormalities. 
Vlll 
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The main focus of this dissertation was to investigate the effect of 
cigarette smoke on DNA damage and repair in human cervical cancer and 
vaginal cells since cigarette smoking is considered a significant cofactor in 
association with high-risk HPV infection in cervical/vaginal carcinogenesis. 
Two types of DNA lesions, namely, DNA strand breaks and oxidative DNA 
damage were analyzed. The findings of this study would serve as an 
essential step in identifying susceptible populations that are at risk for 
developing cervical/vaginal abnormalities. 
1. CervicalNaginal Cancer Statistics 
Cervical cancer is one of the leading cancer types among women 
worldwide, although it has the greatest potential for prevention (World 
Health Organization, PAHO, 2004). In the United States, an estimated 
11 ,270 cases of invasive cervical cancer were diagnosed and 
approximately 4,070 deaths from cervical cancer occurred in 2009 [1]. In 
Kentucky, investigations on cervical cancer is of particular importance, 
since the age-adjusted incidence rate of this cancer for 2002-2006 is 
higher than the average rate in the United States (9.48 versus 8.26 per 
100,000) (Kentucky Cancer Registry 2007). In 2004, current smoking 
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prevalence in Kentucky was the highest in the nation at a rate of 27.6% 
(Center for Disease Control, 2005). The high prevalence of cervical 
cancer has been associated with increased cigarette smoking in the state 
[2]. Based on the Kentucky Cancer Registry data, 61 % of women 
diagnosed with cervical cancer during 1997-1998 had a history of tobacco 
use [2]. 
Vaginal intraepithelial neoplasia is a rare disorder with an incidence 
of approximately 0.2 to 0.3 per 100,000 women [3]. Primary vaginal 
cancer is extremely rare and accounts for about 1- 2% of all gynecological 
malignancies [4]. However, the incidence of secondary vaginal 
malignancies is 80-90% due to the anatomic proximity of the vagina to the 
urinary bladder and rectum. The primary tumors in those locations can 
spread to the vagina either by direct extension or by lymphatic metastasis 
[3]. According to Kentucky Cancer Registry, in 2007, approximately 59% 
of women who were diagnosed with vaginal cancer were smokers 
(Kentucky Cancer Registry 2007). Therefore, studying the role of cigarette 
smoking in cervical and vaginal carcinogenesis could provide prophylactic 
and therapeutic applications that may ultimately be beneficial to women at 
high risk of or diagnosed with HPV-induced cervical/vaginal abnormalities. 
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2. CervicalNaginal Cancer Histopathology 
The morphology of cervical cancer and its pre-cancerous lesions 
are well defined [5], providing an excellent opportunity to study the 
etiology and to strategize prevention of this multi-staged cancer. Based on 
the National Cancer Institute Bethesda System 2001, cervical squamous 
epithelial abnormalities are classified as follows: 
1. Atypical squamous cells (ASC), which encompass two 
subcategories: a) Atypical Squamous Cells of Undetermined Significance 
(ASC-US); and b) ASC with the possibility of high-grade squamous 
intraepithelial lesions (ASC-H) 
2. Low-grade squamous intraepithelial lesions (LSIL), including mild 
cervical intraepithelial neoplasia (CIN I) and HPV 
3. High-grade squamous intraepithelial lesions (HSIL), including 
moderate to severe intraepithelial neoplasia (CIN II/CIN III) and carcinoma 
in situ (CIS) 
4. Invasive squamous cancer 
The progression of cervical intraepithelial neoplasia from CIN I to 
CIN II, CIN III and invasive cancer is based on cytological and epithelial 
architecture abnormality [5]. Less than 5% of low-grade (CIN 1/11) cases 
will progress to high-grade lesions (CIN III), whereas only a small 
4 
percentage of these will be associated with squamous cervical cancer [6]. 
On the contrary, approximately 36-76% of high-grade lesions will progress 
to cervical cancer in about 20 years [6]. The factors influencing the 
progression or regression of the neoplastic lesions are two-fold: genetic 
and environmental determinants [7]. 
The classification of vaginal intraepithelial neoplastic lesions is 
similar to CIN and is classified according to the depth of epithelial 
involvement [8]: 
1. VAIN I: the involvement of the lower one-third or less of the 
distance from the basement membrane to the surface. 
2. VAIN II: less than or equal to two-thirds involvement. 
3. VAIN III: more than two-thirds of the distance is involved. 
Carcinoma in situ (CIS), which the entire thickness of the epithelium is 
involved, is also classified under VAIN III. 
4. Invasive vaginal cancer: vaginal mucosa, submucosa or connective 
tissue is involved without cervical or vulvar invasion. 
Vaginal cancer is usually clustered with "other and unspecified 
gynecologic neoplasms" including vulvar and fallopian tube cancers due to 
its rarity [8]. Vaginal cancers are considered primary if there is no clinical 
or histological involvement of the cervix or vulva [9-10]. 
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3. Cervical versus Vaginal Epithelia 
The cervical epithelium is composed of columnar and stratified non-
keratinizing squamous types. The squamocolumnar junction (also known 
as T -zone) is where those epithelia meet. T -zone is the most important 
cytologic landmark, since most cervical dysplasias arise from this area. 
Squamous metaplasia is a dynamic process that occurs throughout the 
reproductive age in the T-zone, and is a normal physiological process 
during which columnar epithelium is replaced by squamous type. Acidic 
vaginal pH and estrogen account for replacement of more delicate 
columnar epithelium with a more robust squamous type. There are two 
mechanisms responsible for this normal process: 1) reserve cell 
hyperplasia, a proliferation of reserve cells around the columnar glands, 
which eventually leads to the replacement of the epithelium; and 2) growth 
of squamous epithelium toward the center of ectocervical epithelium 
resulting in metaplasia, which, in turn, replaces the overlying columnar 
epithelium. The significance of the T -zone arises from the fact that almost 
all cervical neoplastic lesions originate from this area. During pregnancy 
and peripubertal years, the T-zone is predominantly active, which 
accounts for the observation that early first sexual intercourse and early 
age at first pregnancy are among cervical cancer risk factors. 
Furthermore, it is thought that reserve cells in adolescent and young 
women are more vulnerable to the carcinogenic HPV infection [11-12]. 
6 
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The epithelium of vagina is stratified non-keratinizing squamous 
type. The epithelial cells of vagina are classified into three types: 
parabasal, intermediate and superficial cells, which reflect a 
developmental continuum [11]. 
The vagina lacks a squamocolumnar junction [13], which is not 
necessary for HPV infection, although high-risk HPV distinctively affects 
the T-zone [14]. 
4. CervicalNaginal Cancer Etiology and Risk Factors 
Cervical cancer risk factors can be divided into three groups: 1) 
viral cofactors, such as HPV variants, viral load and viral integration; 2) 
host cofactors, such as endogenous hormones and genetic influences; 
and 3) environmental cofactors, such as diet, use of oral contraceptives, 
parity, cigarette smoking [15-16] and low socioeconomic status [17] 
(Figure 1.1). It has been shown that parity and cigarette smoke are more 
consistently associated with the progression of cervical neoplasia toward 
cervical cancer [15]. The epidemiological and clinical data indicate that 
HPV infection is necessary but not sufficient for development and 
maintenance of cervical carcinoma [18-20], since the majority of HPV 
infections regress [21]. A typical epidemiological profile of CIN includes 
multiple sexual partners, earlier ages at first sexual intercourse, cigarette 
smoking, and lower-socioeconomic status with a strong association with 
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HPV infection [22]. In fact, the HPV prevalence in cervical carcinoma is 
99.7% worldwide, which accounts for the greatest causative factor 
involved in development of any human cancer [23]. 
Human papillomaviruses belong to the Papovaviridae family with a 
double-stranded DNA [24]. Three regions are identified in HPV genome: 
the long control region (LeR), which has no coding potential; the early 
proteins region (E1-E8); and the region of late proteins (L 1 and L2), which 
are structural proteins [24]. There are at least 200 types of HPV viruses 
that are classified into 16 groups according to their ability to induce 
malignant transformation [24]. HPV types 16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59, 68, 73, and 82 are classified as carcinogenic or high-risk 
types [25]. Among these carcinogenic types, HPV 16 and 18 are the most 
closely associated with cervical cancer, with a high prevalence of HPV 16 
[26]. 
In benign cervical precursor lesions, the HPV DNA is usually 
extrachromosomal or episomal, whereas in many cervical cancer cells as 
well as in cervical cancer cell lines and HPV-transformed human 
keratinocytes, the HPV DNA is integrated in the host genome [27]. Upon 
integration of HPV DNA, the viral genome usually breaks in the E1/E2 
region and is usually lost [27]. Moreover, disruption of E2-encoding gene 
causes the loss of expression of viral E2 protein causing uncontrolled 
overexpression of E6 and E7 oncogenes, which is the hallmark of HPV-
induced cervical carcinoma [27-28]. The most significant oncogenes are 
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E6 and E7, which playa major role in HPV-associated tumorigenesis [29]. 
In malignant tissue, E6 and E7 genes are consistently expressed. 
Furthermore, if their expression is inhibited, the malignant phenotype of 
cervical cancer cells is blocked [30]. E6 and E7 oncoproteins cause 
genomic aberrations, mitotic defects, and numerical chromosome 
instability, ultimately leading to carcinogenic progression [31]. The E6 
oncoprotein degrades the cellular protein p53 via the ubiquitin-proteasome 
pathway [32]. E6, then suppresses the p53 gene products [27]. The E7 
oncoprotein interacts with the retinoblastoma protein (pRb) and inactivates 
[33]. pRb plays a crucial role in cell cycle control [34]. Even though HPV is 
a necessary factor in developing cervical abnormalities, it does not suffice 
as a cervical carcinogen, since the majority of the HPV infections are 
short-lived [35]. Additional cofactors are required to prolong expression of 
the HPV E6 and E7 oncogenes and genetic instability [36]. 
The majority of vaginal cancers have common risk factors with 
cervical cancer; the most reported shared risk factor among women with 
cervical and vaginal tumors is infection with cancer-associated HPV types. 
High-risk HPV prevalence is comparable in cervical and vaginal samples, 
which, in turn, signifies that both tissues can retain cancer-associated 
HPV infection [14]. 
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5. Cigarette Smoke Constituents 
The chemical constituents of cigarette smoke have been the 
subject of extensive chemistry analysis. It is well known that smoke 
toxicants are important in the development of various diseases, including 
cancer. More than 5,000 smoke constituents have been identified in 
cigarette smoke and approximately 60 to 70 of those are known toxic 
constituents of tobacco smoke [37]. Tobacco smoking was first listed as a 
human carcinogen in the 9th Report on Carcinogens 2000. This 
identification was based on human studies indicating a casual relation 
between tobacco smoking and cancer (US Department of Health and 
Human Services, Report on Carcinogens, 2000). Tobacco smoking has 
been demonstrated to cause variety of human cancers such as lung, oral 
cavity, lips, larynx, esophagus, and urinary bladder [38]. According to the 
U.S. Department of Health and Human Services, the cigarette smoke 
carcinogens can be summarized in Table 1.1 (US Department of Health 
and Human Services, Report on Carcinogens, 2006). 
Cigarette smoke contains a complex mixture of products resulting 
from organic substance combustion (acetaldehyde and formaldehyde) and 
from chemicals generated by the combustion of tobacco and the 
cigarette's other components (tobacco-specific nitrosamines) (US Surgeon 
General Reports, 1988). The International Agency for Research on 
Cancer (IARC) has listed 36 chemicals that are known human 
carcinogens. Ten of these compounds, in addition to many more 
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mutagenic chemicals fall into Group 2 of IARC's classification of "probably 
or possibly carcinogenic" categories (IARC, 1999). Furthermore, the U.S. 
Environmental Protection Agency and IARC put cigarette smoke in Group 
1 classification as a known carcinogen in humans. 
The U.S. Surgeon General has defined "tar" as the nicotine-free, 
dry, and particulate mass of the tobacco smoke that contains many 
harmful carcinogenic compounds, such as metals, polycyclic aromatic 
hydrocarbons (PAHs), dioxins and nitrosamines (US Surgeon General 
Reports, 1988). PAHs are generated through combustion of any organic 
compound; the highest toxicologically potent of those compounds is 
benzo[a]pyrene (BP), which is extensively studied in relation to human 
carcinogenicity [37]. 
The University of Kentucky's Tobacco and Health Research 
Program developed a cigarette, the 2R4F, which was used as an universal 
standard for research purposes and provided a basis for data comparison 
among scientific communities [39]. Other reference cigarettes, such as 
1 R3F and 1 R5F that have been used in research, differ in the amount of 
chemical constituents compared with 1 R4F (Table 1.2) [40]. 
6. Role of Smoking as a Cofactor in CervicalNaginal Cancer 
Cigarette smoke as a causative factor in the development of 
cervical cancer was proposed by Winkelstein [41]. Based on numerous 
epidemiological studies, cigarette smoke is a significant risk factor in 
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developing cancer of numerous organs [42], including the uterine cervix 
(Figure 1.1) [26, 43-44]. Considering the fact that the cause of cervical 
cancer is multi-factorial and HPV infection alone is not sufficient, although 
necessary, the association of HPV and cigarette smoke has been 
suggested [44-46]. The following data support the hypothesis that 
cigarette smoking is a cofactor with HPV infection in cervical cancer 
etiology [47]: 
1. There is strong association between smoking and CIN II/III/invasive 
cervical cancer [48]. It has been proposed that cigarette smoke has a late 
stage synergistic effect in cervical carcinogenesis already initiated by HPV 
infection [15, 49]. Infection with HPV 16 is demonstrated to be associated 
with high-grade lesions (HSIL), with increasing risk of HSIL directly related 
to number of cigarettes smoked per day [50]. Nakao and Yang et al. used 
an in vitro model system to demonstrate that cigarette smoke may be 
required as a co-carcinogen in the neoplastic progression of HPV-initiated 
high-grade cervical lesions [51-52]. 
2. Detection of tobacco specific carcinogens in cervical mucus such 
as nicotine and cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK) ([53-55] has been reported. These findings support the 
epidemiological data indicating that cigarette smoking is an actual risk 
factor in cervical carcinogenesis. 
3. The association of cigarette smoking as a casual cofactor in 
development of cervical abnormalities is further strengthened by the 
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evidence that tobacco-specific compounds, such as nitrosamine 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene [56-57] 
can be metabolized by human cervical epithelium into carcinogenic and 
genotoxic products. 
4. It has been documented that tobacco smoke is an extreme 
example of systemic human mutagen [58]. The effect of cigarette smoke 
condensate and cigarette smoking, in inducing DNA damage, mainly DNA 
strand breaks, has been demonstrated by many studies [59-62]. Chemical 
carcinogens in cigarette smoke, such as nitrosamines, may damage DNA 
as well as impair local immune response of cervical epithelium [63]. 
Cigarette smoke exerts its cytogenetic effects in various forms, including 
micronuclei, sister chromatid exchange, chromosomal aberrations, 
microsatellite instability, DNA strand breaks and oxidative damage [58]. 
5. Female smokers with HPV-associated low grade cervical lesions 
have up to three times higher risk of developing cervical cancer than 
nonsmokers [48]. Further, cigarette smoking cessation decreases the size 
of early cervical lesions [64]. Therefore, behavioral modification to 
decrease the rate of cigarette smoke consumption [65] may have a 
positive effect on cervical cancer progression and/or development. 
Epidemiological and etiological variables, such as cigarette smoking, 
associated with cervical cancer have also been reported to be pertinent to 
the etiology of vaginal tumors [66]. Few studies have reported a positive 
association between cigarette smoking and vaginal abnormalities [67-70]. 
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These studies were based on an epidemiological association. However, 
conflicting data exist on the role of smoking in the development and 
progression of HPV lesions in vaginal cells. Hellman et al demonstrated 
that vaginal carcinoma was not significantly correlated with smoking [71]. 
Madsen et al found that current smoking was a risk factor in HPV infected 
individuals [66]. Another study by Brinton et al showed a modest non-
significant correlation between smoking and vaginal cancer [72]. Thus, the 
role of cigarette smoking as a cofactor in vaginal cancer remains 
controversial. Nonetheless, the exact mechanism by which cigarette 
smoking exerts its cytotoxic effects is not entirely understood. 
7. Oxidative stress, cigarette smoke and cervical cancer 
Reactive oxygen species (ROS) are abundant free radicals in 
nature and playa significant role in induction of DNA damage [73]. Normal 
cellular processes, such as respiration, inflammation, cell injury and 
hydroxylation of steroids and drugs are endogenous sources of ROS [74]. 
ROS can induce damage in DNA, protein and lipid [75]. Oxidative stress is 
caused by the imbalance between the ROS production, scavenging and 
removal/repair of the resulting damage. Therefore, oxidative stress is 
considered a critical mechanism in the pathogenesis of many diseases 
including cancer [76-77]. Oxidative stress oxidizes cellular components, 
activates signal transduction pathways, affects gene and protein 
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expression and alters activity of DNA polymerase leading to its low fedility 
conformation [78]. The exceptionally important target of oxidation is DNA, 
since mutations induced by such damage may be passed on to many 
generations. The oxidation of guanine to 8-oxo-7,8-dihydro-2'-
deoxyguanosine (8-oxodG) is the most commonly studied oxidative lesion 
[79] (Figure 1.2). This lesion may lead to G.C-' T.A transversions [80]. 
Formation of an oxidative lesion may lead to accumulation and 
persistence of mutation, which may, in turn, playa role in carcinogenicity 
[81-82]. Furthermore, the environmental sources of ROS, such as 
cigarette smoke, are of particular importance in cancer pathogenesis [75]. 
Cigarette smoke can induce different oxidative DNA lesions, including 8-
oxodG [83]. In fact, the role of 8-oxodG formation in cigarette smoke-
induced carcinogenesis has been suggested by many studies. The levels 
of this base lesion were reported higher in smokers as compared to non-
smokers [84-86]. 
8. Cigarette Smoke, DNA repair and Cervical Cancer 
DNA repair machinery is one of the primary defense mechanisms in 
our body against mutagenic agents. There are two subgroups of DNA-
repair genes: 1) genes associated with regulation of DNA repair, and 2) 
genes associated with defined repair mechanisms, such as mismatch 
repair (MMR), nucleotide-excision repair (NER), base-excision repair 
(BER), and double-strand-break (DSB) repair [87]. The NER pathway is 
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responsible for removing bulky DNA adducts caused by tobacco smoke, 
the SER pathway removes oxidized DNA bases caused by endogenous 
agents and/or oxidants in cigarette smoke, and DSS repairs double-strand 
breaks [88]. Homologous recombination (HR) and non-homologous end 
joining are the two complementary pathways of DSS repair [88]. DNA 
lesions, or persisting DNA strand breaks [89] and impaired DNA repair 
system may contribute to genomic instability. 
Tobacco smoke carcinogens damage DNA [62], which 
subsequently involve repair pathways, particularly, NER, SER, and DSS 
repair pathways; the genes of those pathways may be involved in the 
initiation of tobacco-caused cancer [90]. In general, upon exposure to pre-
carcinogenic compounds, the balance between an intact DNA repair 
system and genetic susceptibility may influence conversion of pre-
carcinogenic compounds to DNA damaging agents [91] (Figure 1.3). 
9. p53 and Cervical Cancer 
The continued simultaneous expression of high-risk HPV E6 and 
E7 proteins in cervical cancer causes the inactivation of p53 and pRS 
tumor suppressor pathways, respectively [92]. The tumor suppressor p53 
primarily functions as a transcription factor, but several responses can be 
generated by p53, including cell cycle arrest or apoptosis [93]. p53 gene 
mutations are the most frequently occurred genetic abnormalities in 
human cancers [94]. The role of p53 in cervical pathogenesis is two-fold. 
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First, the short arm of chromosome 17, which is the location of p53, 
showed frequent abnormalities by karyotype analysis of cervical cancer 
specimens [95]. Second, the E6 oncoprotein of high-risk HPV binds to and 
promotes degradation of p53 [96] through a ubiquitin-dependent protease 
system [97]. p53 is inactivated in cervical carcinoma, either by its mutation 
or binding to E6 oncoprotein [98]. p53 mutations frequently occur in HPV-
negative cervical carcinoma cell lines as compared to HPV-positive lines 
[99-100]. 
The role of p53 as an important sensor of cellular stress depends 
on the cell type and extent of stimuli; p53 can induce cell cycle arrest to 
permit repair [101]. Alternatively, p53 can induce apoptosis to prevent 
fixation of DNA mutation in stressed cells [101]. There is also evidence, 
however, that p53 has a more positive role in facilitating the repair of 
oxidative damage. First, activation of several p53-regulated genes yields 
products that act as antioxidants, such as GPX1 and ALDH4A 1 [102-103]. 
Second, two p53-regulated sestrins, namely PA26 and Hi95, can 
reactivate peroxiredoxins, a ubiquitous family of antioxidant enzymes[1 04]. 
Third, several antioxidant genes are up-regulated by p53 resulting in a 
decrease of RDS levels[105]. 
Most HPV-positive cervical carcinoma cells include the wild-type 
p53 gene, although it is usually non-functional as a result of binding to E6 
oncoprotein, which facilitates its degradation via an ubiquitin-dependent 
proteolytic pathway [106]. However, HPV-positive cervical cancer cells 
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have been shown to have residual p53 activity, indicating that p53 is not 
completely inactivated by binding to the E6 oncoprotein [107-109]. The 
p53 gene is often mutated in HPV-negative cervical cancer cell lines [110]. 
10. Rationale/Importance of the Current Studies 
Worldwide, cervical cancer is the second leading cause of cancer 
death after breast cancer among women and the leading cause of cancer 
death in women in developing countries [111]. The World Health 
Organization estimates that 4.5 million smoke-related deaths, which are 
the most preventable cause of deaths, occur each year [111]. Cervical 
cancer in the United States and on a global scale is, therefore, an 
important public health problem. The issue of smoking is of particular 
interest in Kentucky, where the prevalence of tobacco smoking is very 
high (Kentucky Cancer Registry 2007). Moreover, based on available data 
on cervical cancer cases obtained from the Kentucky Cancer Registry 
from 1995-2005, Coker et al showed that cigarette smoking reduces 
cervical cancer survival [112]. The majority of women diagnosed with 
cervical cancer during 1997-1998 had a history of tobacco use [2, 112]. 
These statistics highlight the importance of investigating the plausible link 
between cigarette smoke and cervical cancer to identify the high-risk 
population and lessen the economic and disease burden of Kentucky as 
well as nationwide. Since cigarette smoking is a strong epidemiological 
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and etiological risk factor for cervical and vaginal cancer progression, 
investigation on the effect of cigarette smoke on DNA damage and repair 
in association with HPV infection in those cancers is warranted. 
This study examines the role of cigarette smoke on DNA damage 
and repair. The findings of this study would serve as an essential step in 
identifying susceptible populations that are at risk for developing 
cervical/vaginal abnormalities by developing early biomarkers. Future 
investigations will be warranted to employ the early biomarkers developed 
in this study for clinical settings in order to prevent cervical precancerous 
and cancerous lesions in high-risk population. Furthermore, susceptible 
individuals can be subject to behavioral modification sessions to refrain 
from smoking and be enrolled in chemoprevention studies. In conclusion, 
the data from this study would serve as a stepping stone towards the 
ongoing efforts on primary prevention of cervical/vaginal cancer. 
Chapter II focuses on cigarette smoke condensate (CSC)-induced 
DNA strand breaks and their removal in a human HPV-transfected cervical 
cell line. The role of ellagic acid, a potent antioxidant, in the removal of 
DNA damage was also examined in this chapter. CSC-induced oxidative 
DNA damage and its removal in human cervical cancer cell lines, in 
association with HPV, are examined in Chapter III. Chapter IV, an ex vivo 
study, investigates the effect of cigarette smoking alone and in association 
with high-risk HPV infection in human vaginal cells. 
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11. Rationale for Selecting Vaginal Cells for Ex vivo Study: 
Pap smear contains a heterogeneous cell population, including 
variety of epithelial and non-epithelial cells. To assess the DNA strand 
breaks at a cellular level, in ex vivo study, the first objective was to obtain 
a homogenous sample containing only epithelial cells. Several attempts 
were made to isolate epithelial cells, including magnetic and Percoll 
separation. However, even though the level of cell purity was acceptable, 
the cell recovery did not achieve any significant numbers. Therefore, 
collecting vaginal cells seemed to be the only plausible option to 
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Nature Reviews I Cancer 
Figure 1.1: HPV and non-HPV factors that contribute to HPV-
induced malignant progression [30]. LSIL: Low-grade 
squamous intraepithelial lesion; HSIL: High-grade squamous 
intraepithelial lesion. 
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Figure 1.2: Structures and abbreviations of guanine (Gua), 
deoxyguanosine (dG), 8-oxoguanine (8-oxoGua), 8-oxodeoxyguanosine 
(8-oxodG) and 8-oxoguanosine (8-oxoG), respectively. The asterisk on 8-
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Figure 1.3: The balance of life [91]. 
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TABLE 1.1 
List of Cigarette Smoke Carcinogens 
Chemical Amount (per cigarette) 
Acetaldehyde 980 micro~rams to 1.37 milli~rams 
Acrylonitrile Formerly 1 to 2 milligrams. This product was 
used as a fumigant in tobacco. Its use has since 
been discontinued. 
4-Aminobiphenyl 0.2 to 23 nano~rams per ci~arette 
o-Anisidine Hydrochloride unknown 
Arsenic unknown 
Benzene 5.9 to 75 micro~rams 
Beryllium 0.5 nanograms 
1,3-Butadiene 152 to 400 micro~rams 
Cadmium 1. 7 micro~rams 
1,1-Dimethylhydrazine unknown 
Ethylene oxide unknown 
Formaldehyde unknown 
Furan unknown 
Heterocyclic amines unknown 
Hydrazine 32 micrograms 
Isoprene :3.1 milligrams 
Lead unknown 
2-N aphthylamine 1.5 to 35 nano~rams 
Nitromethane unknown 
N -Nitrosodi-n-Butylamine 3 nano~rams 
N -Nitrosodiethanolamine 24 to 36 nano~rams 
N -Nitrosodiethylamine up to 8.3 nano~rams 
N -Nitrosodimethylamine 5.7 to 43 nano~rams 
N-Nitrosodi-n-Propylamine 1 nanogram 
4-(N -Nitrosomethylamino )-1-(3- up to 4.2 micrograms 
Pyridyl)-I-Butanone 
N-Nitrosonornicotine 14 micro~rams 
N -Nitrosopiperidine unknown 
N -Nitrosopyrrolidine 113 nanograms 
N -Nitrososarcosine 22 to 460 nanograms 
Polonium-210Citation needed variable, depending on soil and fertilizer used to 
~row tobaccoill 
Polycyclic aromatic 80 to 160 micrograms 
hydrocarbons 
0-Toluidine 32 nanograms 
Vinyl chloride 5.6 to 27 nanograms 
From: 11th Report on Carcinogens by the U.S. Department of Health 




e erence Igare es R f C· tt A nalyses 
TPM FTC TAR NICOTINE 
mg/CIG mglCIG mg/CIG 
1R3F' 18.10 15.0 1.16 
1R5F2 2.08 1.67 0.16 
2R4F<! 11.7 9.7 0.85 
1 30 mm butt length (Length of cigarette butt remaining after smoking) 
2 3Smm butt length (Length of cigarette butt remaining after smoking) 
TPM - Total Particulate Matter 
FTC - Federal Trade Commission 
CIG - Cigarette 
From: Chambers, O. The Reference Cigarette. College of Agriculture, 
Reference Cigarette Program. 
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CHAPTER II 
CIGARETTE SMOKE-INDUCED DNA DAMAGE AND REPAIR 




Epidemiological and clinical data strongly support a major role by 
the Human Papillomavirus (HPV) in the etiology of cervical cancer [18-19, 
23]. However, HPV alone appears to be insufficient for cervical cancer 
development as studies have shown that the majority of HPV infection is 
cleared by the immune response within 8-12 months [21]. Further, 
additional cofactors were found to be required for prolonged expression of 
the HPV E6 and E7 oncogenes leading to development and progression 
of cervical abnormalities [36]. One major risk factor in HPV-mediated 
cervical cancer is cigarette smoking, as it has been consistently linked 
with the progression of cervical neoplasias to invasive carcinoma [15]. 
Further, female smokers have two times higher risk of developing cervical 
cancer than non-smokers [114]. 
Cigarette smoke-induced genotoxicity results in induction of 
micronuclei, sister chromatid exchange, chromosomal aberrations, 
microsatellite instability, DNA strand breaks and oxidative DNA damage 
[58, 115]. Cigarette smoke is a heterogeneous mixture of approximately 
5,000 chemical compounds, of which several dozens of them are 
carcinogens, co-carcinogens, mutagens and tumor promoters [116], 
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including polycyclic aromatic hydrocarbons (PAH), N-nitrosamines, 
inorganic and organic compounds [117-118]. 
Cigarette smoke has been shown to cause a variety of oxidative 
DNA damage, including the formation of 8-oxo-7,8-dihydro-2-
deoxyguanosine (8-oxoguanine) [119-120]. 8-0xoguanine is a common 
mutagenic DNA lesion which is formed abundantly by intracellular 
oxidation and exogenous carcinogens like cigarette smoke [86, 121]. It 
has also been shown that cigarette smoke induces other forms of DNA 
damage, including single-strand breaks (SSBs) [59, 62] and possibly 
double-strand breaks (DSBs) [122-123]. In general, strand breaks result 
from the attack of a variety of endogenous and exogenous factors to the 
sugar residues of DNA [124]. SSBs represent the initial DNA damage and 
are often used as a biomarker of exposure [125-127]. DSBs are 
considered to be more biologically relevant since they can lead to 
chromosome translocation and cancer if repaired improperly in addition to 
genetic instability and cell death if left unrepaired [128]. Cellular DNA 
repair capacity is of particular importance since it is a primary factor in 
how well a cell can overcome DNA insults by a genotoxic agent. An intact 
DNA repair system is crucial in order to combat the effects of various 
carcinogens which can induce DNA damage. 
HPV-transfected cervical cells were chosen since it has been 
proposed that cigarette smoke has a late stage synergistic effect in the 
cervical carcinogenesis already initiated by HPV infection [15, 129]. In 
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order to study the role and possible mechanisms of cigarette smoke-
induced DNA damage in the cells we employed Single Cell Gel 
Electrophoresis (SCGE), also known as the comet assay. It is a sensitive 
technique to detect DNA strand breaks as well as assess DNA repair 
kinetics at the single cell level [125, 130]. We have employed comet assay 
[131-132] to investigate (i) single- and double-strand DNA breaks following 
exposure of the HPV16-transformed human ectocervical cell line 
(ECT1/E6 E7) to cigarette smoke condensate (CSC); (ii) the ability of the 
cells to repair CSC-induced DNA damage; and (iii) the possibility of 
oxidative damage as the source of CSC-induced DNA strand breaks by 
employing ellagic acid (EA) as a known scavenger of reactive oxygen 
species [133-134]. 
B. Materials and Methods 
1. Materials 
Keratinocyte serum-free medium (K-SFM), bovine pituitary extract 
(BPE), epithelial growth factor (EGF), penicillin/streptomycin, 
trypsin/EDT A solution and low-melting agarose were from Invitrogen 
(Carlsbad, CA, USA); sodium N-Iauroyl sarcosine, DMSO, Tris and 
spermine were from Sigma Aldrich (St. Louis, MO, USA); proteinase K 
was from Roche (Switzerland); EDTA was from Mallinckrodt Chemicals 
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(Hazelwood, MO, USA); and ellagic acid was from LKT Laboratories (St. 
Paul, MN, USA). 
2. Preparation of esc 
University of Kentucky research cigarettes (2R4F) were smoked in 
a Borgwardt 30-port smoking machine under standard FTC protocol [135]. 
The particulates were collected on Cambridge filters and were dissolved in 
DMSO to obtain a 4% solution. The stock cigarette smoke condensate 
solutions were stored in small aliquots at -80° C. A fresh vial was used for 
each experiment. 
3. DNA damage formation 
HPV-16 transformed human ectocervical cells, ECT1/E6 E7, were 
a generous donation by Dr. Raina Fichorova, Brigham and Women's 
Hospital, Harvard Medical School. The cells were routinely cultured as 
monolayer in K-SFM supplemented with 0.3% BPE, 0.1 ng/ml EGF, 0.4 
mM CaCI2, 1 % penicillin and streptomycin at 37°C and 5% CO2. Cells were 
seeded at a density of approximately 6,000 cells/cm2 in 25 cm2 cell culture 
flasks. After cells reached 60 to 70% confluence, they were treated with 
either 0.2% v/v DMSO or with 4, 8 and 12 Ilg/ml CSC in DMSO for up to 
96 h in order to induce the maximum DNA strand breaks and then 
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harvested by trypsin/EDTA solution. The cells were kept on ice at all times 
to minimize the DNA repair. All cell culture studies were performed 
independently three or four times. 
4. DNA repair 
ECT1/E6 E7 cells were treated with 4, 8 or 12 Ilg/ml CSC for 72 h, 
followed by CSC withdrawal. Residual CSC was removed by washing the 
cells three times with 5 ml medium, followed by incubation of the cells with 
the fresh medium for an additional 24, 48, or 72 h at 37°C to allow repair 
of DNA strand breaks to occur. 
5. Ellagic acid treatment 
ECT1/E6 E7 cells were pre-treated with EA (5 or 15 11M, 0.2% 
DMSO) for 20 h. Following this, medium was removed and fresh media 
containing CSC (4, 8 or 12 Ilg/ml, 0.2% DMSO) and EA (5 or 15 11M, 0.2% 
DMSO) were added for 72 h. Vehicle (0.2% DMSO)-treated controls were 
analyzed in parallel. 
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6. Comet Assay 
DNA single- and double-strand breaks were detected by alkaline 
and neutral comet assays, respectively, as described [130-131]. Briefly, 
100,000 cells per slide were embedded in 1 % low-melting agarose on 
frosted microscopic glass slides. The cells were subsequently lysed (1.25 
M NaCI, 0.1 % sodium N-Iauroyl sarcosine, 50 mM Na-EDTA, 100 mM 
Tris-HCI, pH 10), digested with proteinase K (1.25 M NaCI, 5 mM EDTA, 5 
mM Tris-HCI, 0.5 mg/ml proteinase K, pH 10) and DNA precipitated (50% 
ethanol, 1 mg/ml spermine, 20 mM Tris-HCI, pH 7.4). 
For single-strand breaks, the DNA was unwound by first soaking 
the slides in strong alkaline buffer (10 mM Na-EDTA, 3 M NaCI, pH 13) 
and then electrophoresed in the same buffer (26 V; 400 mA, at 4°C). For 
double-strand breaks, the DNA was uncoiled using a neutralizing buffer 
(500 mM Na-EDTA, 0.2% DMSO, 500 mM NaCI, 100 mM Tris-HCI, pH 9) 
and then electrophoresed in the same buffer (26 V; 250 mA at 4°C). 
After staining the cells with ethidium bromide, comets were 
visualized using a light microscope attached to a digital camera with 510 
excitation and 590 emission filters. The images were analyzed using the 
software Comet Assay IV. (Perspective Instruments, Haverhill, UK). A total 
of 50 cells per slide and 2 slides per sample were scored for "tail length" 
and "tail moment". Tail length is defined as the distance between the 
center of the comet head and the end of the tail. Tail moment is often 
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considered a more significant indicator of DNA damage since it refers both 
to the distance of DNA migration and the amount of DNA in the tail [136]. 
The higher the values of tail length and tail moment, as computed by the 
software, the higher the level of DNA damage. 
c. Statistical analysis 
The differences between comet assay mean values were analyzed 
for statistical significance (p < 0.05) using Student's t-test. Statistical 
analysis of dose response was calculated using one-way Analysis of 
Variance (ANOVA). 
D. Results 
1. Effect of esc on DNA strand breaks with time 
Figure 2.1 depicts the typical comet-like appearance of DNA strand 
breaks. ECT1 E6/E7 cells were treated with vehicle and 8 !-Ig/ml CSC for 
24, 48, 72, and 96 h (Fig. 2.2). The cell viability, as measured by trypan 
blue dye exclusion, following a dose of 8 !-Ig/ml CSC (up to 72 h) was ~ 
80% contributing to lower background damage and therefore considered 
ideal to study time response (data not shown). Since the rate of induction 
of single- and double-strand breaks was almost the same (as described 
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below} only single-strand breaks were measured. There was a time-
dependent increase (Figure 2.2) in cells with single-strand breaks for both 
tail length, (2.9 fold; p < 0.0001), and tail moment (14.4 fold; P = 0.0109), 
at 72 h, compared to 0 h. Beyond 72 h, the tail length and tail moment 
plateaued. Taking this into account, the 72 h time point was chosen to 
conduct the DNA damage and repair studies, since the maximum DNA 
strand breaks occurred at this treatment time. 
2. Single- and double-strand breaks induced by different doses 
ofCSC 
Cells treated with CSC showed a clear dose-response with respect 
to the tail length and tail moment from 4-12 !-Ig/ml of CSC for both single-
and double-strand breaks (p < 0.0001) (Figure 2.3). The rate of single-
and double-strand break occurrences was essentially the same at all 
doses tested at 72 h of CSC treatment for tail length. The tail moment for 
double-strand breaks was slightly lower as compared to single-strand 
breaks, although not statistically significant. 
Doses of CSC higher than 12 !-Ig/ml had a lethal effect on the cells 
(not shown). Treatment of the cells with 12 !-Ig/ml CSC for 72 h generated 
the longest comet tail indicating the largest number of strand breaks, 
which represents an increased number of DNA fragments. Panels 3c and 
3d represent the number of cells with single- and double-strand breaks, 
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respectively distributed at certain tail lengths following treatment with 0, 4, 
8, and 12 IJg/ml concentrations of CSC; increase in concentration of CSC 
indicates a greater number of strand breaks. 
3. DNA repair studies 
A significant amount of both single- and double-strand breaks were 
repaired in the first 24 h following treatment with 4, 8 and 12 IJg/ml CSC 
for 72 h (Figure 2.4): At the highest concentration of CSC, tail length and 
tail moment of single strand breaks were repaired by 27% and 32%, 
respectively after 24 h; tail length and tail moment of double-strand breaks 
were repaired by 21 % and 44%, respectively at the same concentration. 
No further removal of either single- or double-strand breaks was observed. 
DNA repair at the two lower concentrations of CSC followed essentially 
the same kinetics (Figure 2.4). 
4. Ellagic acid and oxidative damage 
Cells treated with 5 11M EA showed a reduction in the level of 
single-strand breaks measured both as tail length (9%) and tail moment 
(15%) although not statistically significant (Figure 2.5). At a higher dose 
(15 11M) of EA, however, single-strand breaks were diminished 
significantly - 28% (p = 0.0019) reduction in tail length and 50% (p = 
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0.0115) reduction in tail moment (Figure 2.5). The tail length of double-
strand breaks were also significantly reduced by nearly 8% (p = 0.0076) 
and 14% (p = 0.0042) with 5 and 15 11M EA treatment, respectively. The 
tail moment, however, was unaltered. 
E. Discussion 
It has been reported that cigarette smoke has a late stage 
synergistic effect in cervical carcinogenesis initiated by HPV infection [15, 
129]. Nonetheless, the mechanism of smoking on the neoplastic 
progression of cervical cells remains inconclusive. The aim of this study 
was to investigate CSC-induced DNA damage and subsequent repair in 
HPV-immortalized cervical cells. In order to further understand the 
interplay of smoking and cervical carcinogenesis, we employed the comet 
assay to measure single- and double-strand DNA damage and 
subsequent repair. 
The principle of the comet assay is based on alterations found in 
DNA such as strand breaks resulting in the extension of DNA loops from 
lysed and salt-extracted nuclei, which, in turn, form a comet-like tail after 
either alkaline electrophoresis, indicating SSBs, or neutral electrophoresis, 
indicating DSBs [130, 137]. In previous studies in which the effects of 
cigarette smoke condensate/cigarette smoke on DNA strand breaks were 
investigated by the comet assay, only DNA single-strand breaks were 
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detected [62, 138-139]. The interaction of ese on DNA strand breaks in 
HPV-transformed cervical cells has not been reported previously. 
In the present study, we showed that ese in HPV-infected cervical 
cells is able to induce similar levels of DNA single- and double-strand 
breaks in a dose- and time-dependent manner. Based on experimental 
and epidemiological studies, cigarette smoke accounts for a significant 
risk factor in developing cancer of various organs [42], including those of 
the cervix [26, 43-44]. Numerous genotoxic effects of ese, including DNA 
strand breaks, have also been demonstrated in other human culture cells 
[59-62, 140]. However, this finding has not been demonstrated previously 
in HPV-infected cervical cells. We speculated that DNA integrity is 
compromised when cigarette smoke acts in conjunction with HPV in the 
cells. Nonetheless, the effects of ese as a heterogeneous component on 
the extent of DNA damage in the cells are complex. Moreover, since ese 
consists of many tumor promoters such as catechol and hydroquinone 
[141] as well as inhibitors such as unsaturated aldehydes [142], it is 
difficult to pinpoint the specific carcinogens, present in ese, which are 
responsible for DNA strand breaks. Our finding supports epidemiological 
data suggesting that cigarette smoke acts in synergy with HPV in cervical 
carcinogenesis. 
In the current study, single- and double-strand breaks were two 
types of DNA damage investigated. SSBs are considered an indicator of 
early damage [125]. Also, SSBs are intermediate processing products of 
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DNA damage, which, if left unrepaired, may develop into mutagenic and 
lethal double-strand breaks [143]. Conversely, DSBs are considered more 
biologically relevant lesions [125]. DSBs are a more disruptive form of 
strand break since they can either lead to cell death or loss of genetic 
information, if left unrepaired, or they may cause neoplastic progression if 
the repair process is compromised [128, 144]. 
Since the DNA repair capability is an important factor believed to 
influence the outcome of DNA damage, we examined the repair efficiency 
of HPV-transformed cervical cells in combating CSC-induced strand 
breaks. From our results, it appears that cells attain DNA single- and 
double-strand breaks at all concentrations of CSC tested and that 
maximum repair of DNA single- and double-strand breaks occurred during 
the first 24 h and plateaued afterwards. The present study also suggests 
that the repair of CSC-induced DNA damage occurred only during the first 
24 h and no further repair was observed. This trend was observed for both 
single- and double-strand breaks. This observation is in agreement with 
radiation-induced SSBs in leukocytes [145] and SSBs and DSBs in mouse 
embryo fibroblasts [125]. In the latter study, in contrast to the current 
findings, SSBs were completely repaired after 24 h post radiation, 
whereas DSBs were not [125]. Additionally, based on our repair studies, 
the ability of the cells to repair CSC-induced DNA strand breaks reached a 
plateau after first 24 h regardless of CSC concentration. Therefore, it can 
be concluded that the cellular repair response depends on the cell type, 
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the nature of strand breaks, the type of carcinogen as well as the DNA 
repair capacity of the cells. It is possible that at CSC concentrations lower 
than the ones tested in this study, ECT1/E6 E7 cells endure less strand 
breaks, which could be repaired efficiently. However, if DNA repair 
capacity of the cells is compromised due to the HPV infection, the CSC-
induced breaks may be poorly repaired which may lead to the 
accumulation of mutations. 
It has been reported that HPV infection compromises the DNA 
repair system such as alteration in gene amplification, expression of DNA 
repair enzymes [146] and microsatellite instability [147]. It is conceivable 
that expression and function of genes responsible for the repair of strand 
breaks might be responsible for the differences in the rate of the repair of 
CSC-induced damage. The repair of HPV16-immortalized ectocervical 
epithelial cells to PAHs, such as benzo(a)pyrene (BP), present in cigarette 
smoke, was found to be impaired due to reduced p53 in those cells [148]. 
Moreover, BP has been shown to manipulate multiple HPV life cycle 
functions, which, in turn, may influence cervical cancer progression [149]. 
Cigarette smoke may also contribute to the deficiency of DNA 
repair in rejoining of the strand breaks. In this study, both single- and 
double-strand DNA breaks were highly persistent. We found that CSC-
induced DNA damage was much more persistent than ionizing radiation-
induced damage which was completely repaired within 2 h [62]. This 
finding might be due to genotoxic compounds present in CSC which have 
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been shown to slow DNA repair kinetics [62]. It has been reported that 
acrolein, also a constituent of cigarette smoke, was found to inhibit the 
repair of DNA damage [150]. Therefore, it is reasonable to conclude that 
impaired DNA repair by CSC may have a role in fixation of DNA damage 
in cervical cells, leading to accumulation of mutations and cancer 
development. In theory, SSBs should be repaired by using the 
undamaged strand as a template, whereas DSBs can be repaired by two 
repair pathways, namely homologous recombination or non-homologous 
end-joining [125, 151]. Indeed, further investigation is required to identify 
the repair pathway that may have been affected in the CSC-induced 
cervical cells. To the best of our knowledge, this is the first demonstration 
of the kinetics of CSC-induced DNA strand breaks and of global repair of 
the damage in human cervical cells. 
In order to investigate if free radicals are the source of oxidative 
DNA damage, we examined the effect of an antioxidant, EA, in mitigating 
CSC-induced DNA damage. In our investigation, EA showed significant, 
dose-dependent reduction in CSC-induced single- and double-strand 
breaks. Cigarette smoke contains a broad range of carcinogens, including 
redox-active catechols, which may lead to the induction of oxidative stress 
and eventually contribute to increased genomic instability and cancer 
development [152-153], including cervical cancer [154]. It has been 
reported that the highly reactive hydroxyl radicals generated from Cigarette 
smoke contribute in the formation of DNA single-strand breaks in vitro [59, 
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120]. EA is a phenolic lactone that exerts its anticarcinogenic and 
antimutagenic activities through several mechanisms, including 
scavenging reactive oxygen species [133, 155-156]. This observation is in 
agreement with previous studies investigating the antioxidant activities of 
EA on DNA strand breaks [157-158]. Our data suggest that CSC-induced 
DNA strand breaks may, in part, originate from free radicals. 
Interestingly, we found that EA did not significantly reduce basal 
levels of both single- and double-strand breaks. Based upon our findings, 
we speculate that there may be two possible explanations for the lack of 
attenuation of basal levels of DNA strand breaks. First, cigarette smoke 
contains more than 5,000 chemicals with diverse interactions [158], which 
may influence the effectiveness of EA to act as an antioxidant. Second, in 
our laboratory, it has been reported that EA was a potent inhibitor of 
dibenzo[a,l]pyrene-DNA adducts in a microsome-mediated test system by 
~ 75% [159]. However, using a cellular system, EA inhibited the same 
adducts by only 16% [160]. Thus, it seems reasonable to speculate that, in 
the present study, limited EA uptake by the cells may be a possibility for 
lower inhibition of CSC-induced oxidative stress in the presence of the 
antioxidant. Despite the fact that EA has antioxidant activity and is a direct 
radical scavenger [133], the mechanisms by which EA can further reduce 
DNA strand breaks induced by CSC in the cervical cells await further 
study. There are ongoing experiments in this laboratory to further 
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investigate whether reactive oxygen species are a source of CSC-induced 
DNA damage in the HPV- infected cervical cells. 
In conclusion, our study highlights the inability of HPV-transfected 
cells to completely repair CSC-induced DNA damage. Furthermore, we 
demonstrated that the oxidative stress may be the source of DNA damage 
caused by CSC. The significance of our study stems from the fact that 
DNA lesions and/or persistent DNA strand breaks [89], caused by the 
inability of the cells to remove the damage, may result in accumulation of 
mutations leading to cancer. These findings support the previously found 
epidemiological association between HPV infection, cigarette smoke 
exposure and cervical cancer development [46, 161]. Our result suggests 
that cigarette smokers infected with HPV may be at a higher risk for 
cervical cancer. 
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Figure 2.1: Representative comet assay images showing single-strand 
breaks in DNA of ECT1/E6 E7 cells treated with vehicle, 0.2% DMSO (a), 






















Figure 2.2: Time response of CSC on DNA single-strand formation as 
detected by (a) mean tail length (b) mean tail moment in alkaline comet 
assay following treatment of cells with 8 Ilg/ml CSC. Data represent mean 
± SO of 4 independent experiments. 
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Figure 2.3: Dose response of esc on single- and double-strand breaks: 
(a) mean tail length; (b) mean tail moment; and (c) and (d) distribution 
pattern of cells with single- and double strand breaks, respectively as 
measured by tail length after 72 h, respectively. Data represent mean ± 
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Figure 2.4: Repair of single- (a, b) and double-strand (c, d) DNA breaks. 
a, c: tail length; c, d: tail moment. Cells were treated for 72 h with 0 (~), 4 
(---+--},8 (---) and 12 ( .......... ) IJg/ml CSC, freed from residual CSC, and then 
incubated for up to 72 h for DNA repair to occur. Data represent mean ± 
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Figure 2.5: Effect of ellagic acid on cigarette smoke condensate-induced 
single- and double-strand DNA breaks as measured by tail length (a) and 
tail moment (b). The cells were pretreated with 5 or 15 11M ellagic acid for 
20 h, followed by co-treatment with 8 Ilg/ml cigarette smoke condensate 
for 72 h. Data represent mean ± SD of 3 independent experiments. *P < 
0.05 .• single-strand breaks; SlIouble-strand breaks. 
47 
CHAPTER III 
CIGARETTE SMOKE CONDENSATE-INDUCED OXIDATIVE DNA 
DAMAGE AND ITS REMOVAL IN HUMAN CERVICAL CANCER CELLS 
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A. Introduction 
A role of cigarette smoking as a causative factor in the 
development of cervical cancer was proposed by Winkelstein [41]. 
Considering the fact that the cause of cervical cancer is multifactorial and 
HPV infection alone is not sufficient but necessary in its etiology, the 
interaction of HPV and cigarette smoke has been proposed [44-46]. The 
effects of cigarette smoke as a heterogeneous component on the extent of 
oxidative DNA damage in cells are two-fold. First, the tar and gas-phase of 
smoke are rich sources of free radicals, such as the quinone-
hydroquinone-semiquinone system and nitric oxide [162], which can 
induce different oxidative DNA lesions, such as 8-oxo-7,8-dihydro-2'-
deoxyguanosine (8-oxodG) [163]. Second, the involvement of cigarette 
smoke free radicals in carcinogenesis has been well documented and 
reviewed elsewhere [75, 164-165]. The levels of oxidative base lesions 
were reported higher in smokers as compared to non-smokers [84-86]. 
Insight into the mechanisms by which DNA of high-risk HPV transforms 
cervical cells arose from the realization that the virus oncoproteins interact 
with specific cell regulatory proteins. The E6 oncoprotein causes 
degradation of the cellular protein p53 by the ubiquitin-proteasome 
pathway; the E7 oncoprotein interacts with the retinoblastoma protein and 
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inactivates it [32]. The tumor suppressor p53 primarily functions as a 
transcription factor, but several responses can be generated by p53, 
including cell cycle arrest or apoptosis [93]. The status of p53 in cervical 
cancer has previously been investigated. It appears that the inactivation of 
the normal function of p53 is a critical step in human cervical 
carcinogenesis, which can be either caused by mutation, as in HPV-
negative cells [166], or from complex formation with E6 oncoproteins in 
case of HPV-positive cervical cancer cells [97]. 
HPV-positive cervical cancer cells have been shown to possess 
residual p53 activity indicating that p53 is not completely inactivated by 
binding to E6 oncoprotein [107-109]. These findings might indicate the 
possibility of p53 involvement in HPV-positive cells' response in removing 
the oxidative DNA damage. There is evidence that p53 has a more 
positive role in facilitating the repair of oxidative lesion by its involvement 
in base excision repair (BER), a DNA repair pathway [167]. However, the 
existence of p53-independent repair pathway should also be considered 
since cells devoid of HPV sequence did not show a p53-mediated 
response to oxidative DNA damage [168]. 
This work was designed to investigate i) the effect of CSC on 8-
oxodG formation in and its removal from HPV-transfected (ECT1/E6 E7), 
HPV-positive (CaSki) and HPV-negative (C33A) human cervical cancer 
cells; and ii) the cell-cycle progression and apoptosis in the CSC-treated 
ECT1/E6 E7 cells. The transfected cell line was chosen as a standardized 
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in vitro model [169] to further understand the interplay of cigarette smoke 
free radicals and cervical carcinogenesis. 
B. Materials and Methods 
1. Cell Lines and cell culture 
HPV-16 transformed human ectocervical cells, ECT1/E6 E7, were a 
generous donation by Dr. Raina Fichorova, Brigham and Women's 
Hospital, Harvard Medical School. HPV-16 positive human cervical cells, 
CaSki, and HPV-negative human cervical cells, C33A, were purchased 
from ATCC (Manassas, VA). ECT1/E6 E7 cells were cultured as 
monolayer in K-SFM supplemented with 0.3% BPE, 0.1 ng/ml EGF, 0.4 
mM CaCI2, 1 % penicillin and streptomycin at 37°C and 5% CO2. CaSki and 
C33A cells were routinely cultured in RPMI-1640 media supplemented 
with 5% fetal bovine serum (FBS) in a humidified atmosphere of 5% CO2 
in air at 37°C. All the cell lines were seeded at a density of approximately 
6,000 cells/cm2 in 25 cm2 cell culture flasks. All the cell lines were 
authenticated by DNA (STR) profiling at the Core Fragment Analysis 
Facility at Johns Hopkins University on March, 15, 2010. 
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2. Preparation of esc 
University of Kentucky research cigarettes (2R4F) were smoked in 
a Borgwardt 30-port smoking machine under standard FTC protocol [135]. 
The particulates were collected on Cambridge filters and were dissolved in 
DMSO to obtain a 4% solution. The stock CSC solutions were stored in 
small aliquots at -80°C. A fresh vial was used for each experiment. 
3. 8-oxodG formation 
CSC treatment of the cells was carried out as described 
elsewhere [170]. Briefly, after cells reached 60 to 70% confluence, they 
were treated with either 0.2% v/v DMSO or with 4, 8 and 12 Ilg/ml CSC in 
DMSO for up to 72 h in order to induce the maximum oxidative DNA 
damage and then harvested by trypsin/EDT A solution. The cells were kept 
on ice at all times to minimize the DNA repair. 8-oxodG formation was 
measured by flow cytometry. 
4. DNA repair 
The cells were treated with 4, 8 or 12 Ilg/ml CSC for 72 h. Residual 
CSC was removed by washing the cells three times with 5 ml medium, 
followed by incubation of the cells with the fresh medium for an additional 
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24, 48, or 72 h at 37°C to allow repair of oxidative DNA damage to occur. 
Subsequently, 8-oxodG levels were measured by flow cytometry. 
5. Flow cytometry and ImageStream analysis of 8-oxodG and p53 
expressions 
Primary polyclonal goat anti-8-0HdG antibody was purchased from 
Chemicon International; and primary polyclonal goat anti-p53 antibody 
was purchased from Santa Cruz biotechnology. Briefly, all cell lines were 
harvested and fixed in 70% ethanol and stored at -20°C for later 
processing. Upon thawing, cells were washed one time in phosphate 
buffered saline (PBS) followed by another wash with FACS buffer (1 % 
BSA in PBS). Next, cells were permeabilized with 0.1 % Triton-X-100 for 
20 minutes on ice at room temperature (RT), followed by washing with 
PBS. For 8-oxodG staining, primary antibody (1-3 mg/ml) was incubated 
with Zenon Fab-Alexa Fluor 488 goat IgG labeling reagent (5 Ill) 
(Invitrogen, Carlsbad, CA), and cells were stained for 30 min at room 
temperature in dark. Alternatively, to stain for p53, fixed, washed and 
permeabilized cells were stained with 1 Ilg p53 primary antibody labeled 
with 5 III of the Zenon Fab-Alexa Fluor 488 goat IgG labeling reagent for 
30 min at room temperature in dark. Cells were washed with FACS buffer. 
For nuclear staining, 106 cells were incubated with 0.25 Ilg of 7-Amino-
Actinomycin D (7 AAD; BD-PharMingen) resuspended in FACS buffer and 
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analyzed within 30 min. Around 5 x 104 cells were analyzed by flow 
cytometry using a FacsCalibur flow cytometry and CeliQuest™ software 
(Becton-Dickenson, USA) to assess cell cycle, apoptosis and p53 
expression. Expression of p53 was defined in terms of total fluorescent 
intensity, which was calculated by multiplying number of cell events by 
mean intensity. Correspondingly, 104 stained cells were analyzed using an 
ImageStream System and IDEAS 3.0 software (Amnis) to assess 8-oxodG 
expression. 8-oxodG total fluorescent intensity was calculated by 
multiplying the cell events by mean fluorescent intensity. 
6. Cell cycle analysis 
Cell cycle phase distribution of ECT1/E6 E7 cells was analyzed by 
flow cytometry (BD Biosciences, San Jose, CA). CSC-treated cells and 
appropriate controls (2 x 105) were collected after 24 h, washed twice with 
PBS and fixed with ice-cold 70% ethanol at 4°C for 30 min to 1 h. The 
cells were then treated with 10 Ilg/ml propidium iodide (PI, Sigma- Aldrich, 
St. Louis, MO), 2.5 Ilg/ml RNase A (Sigma- Aldrich, St. Louis, MO) and 
0.1% Triton X-100 in dark at 37°C for 30 min. Data were collected, stored 
and analyzed using FlowJo software (Becton Dickinson). 
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7. Apoptosis detection 
Apoptosis in ECT1/E6 E7cells was detected using an Alexa Fluor® 
488 annexin V/propidium iodide kit (Invitrogen Co., Carlsbad, CA), 
according to the manufacturer's instructions. Briefly, 1 x 106 cells were 
treated with vehicle or 4, 8, 12 Ilg/ml CSC for 24 h. After harvesting, cells 
were washed with cold PBS, and then stained with 5 III annexin V-FITC 
and 0.1 Ilg/ml propodium iodide (PI) for each 100 III of cell suspension 
and incubated at room temperature for 15 min. The apoptotic cells were 
determined using FACScalibur flow cytometry (Becton Dickinson, San 
Jose, CA). Data analysis was performed using FlowJo software (Becton 
Dickinson). It is important to note that a quadrant quantification method 
could not be used in apoptotic cell determination, since CSC treatment 
affected the cells' distribution using that method. Therefore, both early 
apoptotic (Annexin V-positive and PI-negative) and late apoptotic (Annexin 
V-positive and PI-positive) cells were determined in the cell death 
determination. 
c. Statistics 
The total fluorescent intensity levels are expressed as the mean ± 
SD (standard deviation) and analyzed for statistical significance (p < 0.05) 
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using Student's t-test. Statistical analysis of dose response was calculated 
using One-way Analysis of Variance (ANOVA). 
D. Results 
1. 8-0xodG formation in HPV-transfected cervical cells 
A significant increase (3-fold; p = 0.004) in 8-oxodG level was 
detected following treatment of cells with 12 Ilgfml CSC for 24 h compared 
with vehicle treatment (Fig. 3.1 a,b); the 8-oxodG levels were further 
increased (3-fold; p = 0.01) after 72 h (Fig. 3.1 c,d). Formation of 8-oxodG 
lesion was both dose- (p = 0.01) and time- (p = 0.002) dependent (Fig. 
3.1 e,f). 
2. 8-0xodG removal in cervical cells 
To examine the ability of cervical cells to remove CSC-induced 
oxidative DNA damage, we investigated the residual 8-oxodG total 
fluorescent intensity for different periods of recovery time. The highest 
level of oxidative DNA damage measured as total fluorescent intensity x 
105 was found to be in ECT1 fE6 E7 cells (104 ± 19), followed by CaSki 
(2.7 ± 0.71) and C33A (0.66 ± 0.083) cells. 
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ECT1/E6 E7 and C33A cells showed a 3- (p = 0.007) and 2-fold (p 
= 0.02) increase in 8-oxodG level in the first 24 h, respectively (Fig. 3.2a, 
c, iv). In contrast, a 3-fold (p = 0.07) decrease in oxidative damage was 
observed in CaSki cells in the first 24 h (Fig. 3.2b, iv). However, 8-oxodG 
lesion was essentially removed from all the cell lines by 72 h (Fig. 3.2a, b, 
c: i, ii, iii, iv). 
3. p53 assessment in cervical cells 
The different cervical cells treated with vehicle or CSC during the 
repair phase of 8-oxodG were also analyzed for p53 levels in order to 
elucidate its involvement in cell cycle phase distribution, apoptosis 
induction, and removal of oxidative DNA lesion. As quantified by flow 
cytometry. p53 total fluorescent intensity was increased by 2 and 5 fold in 
ECT1/E6 E7 (Fig. 3.3a) and CaSki cells (Fig. 3.3b), respectively, but it 
was diminished by 1.7 fold in C33A cells (Fig. 3.3c). 
4. Cell cycle phase distribution in HPV-transfected cervical cells 
p53 is non-functional in cervical cells harboring HPV infections due 
to the co-expression of the E6 oncoprotein. Therefore, a CSC-induced cell 
cycle arrest is not expected in these cells. To test this, we investigated the 
cell cycle changes in immortalized cervical cells after CSC exposure for 24 
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h. Nearly one half (46.6%) of vehicle-treated cells were at G1 phase, 
24.9% in S phase and and 28.3% in G2 phase. After treatment with CSC 
(12 Ilg/ml), the G1 phase cells increased to 60.3% while the proportion of S 
phase decreased to 17.4%. However, there was no significant change in 
percentage of cells in G2 phase post-CSC exposure (Fig. 3.4). These data 
suggest that CSC treatment resulted in GoIG 1 phase arrest. 
5. Apoptosis induction in HPV-transfected cervical cells 
We examined the percentage of cells going through apoptosis as a 
possible mechanism by which CSC affects cells. CSC treatment induced 
apoptosis, as evidenced by a dose-dependent increase in the percentage 
of apoptotic cells at 24 h treatment in ECT1/E6 E7 cells: 9.7% of vehicle-
treated cells were apoptotic which increased to 11.5%, 16.6%, and 26.6% 
after treatment with 4, 8, 12 Ilg/ml CSC treatment, respectively. Fig. 3.5 
depicts the effect at the highest concentration tested. 
E. Discussion 
We previously showed that CSC can induce both dose- and time-
dependent single- and double-strand breaks in cervical cells [170]. In the 
present study, we show that CSC induces 8-oxodG lesion in a dose- and 
time-dependent fashion in the HPV-transfected cervical cell line, ECT1/E6 
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E7. It is well documented that cigarette smoke or its components induce 
oxidative DNA damage [58], which is believed to be highly mutagenic and 
carcinogenic [171]. In the present study, the highest levels of oxidative 
DNA damage was observed by treatment of cervical cells with 12 Ilg/ml 
CSC for 72 h. This highlights the inherent vulnerability of cervical cancer 
cells to CSC-induced oxidative stress; a dose- and time-related increase 
in 8-oxodG lesion in cervical cells emphasizes the important role of the 
CSC-induced oxidative DNA damage in cervical carcinogenesis. Our 
finding supports epidemiological and experimental data suggesting that 
cigarette smoke induces oxidative stress. 
Furthermore, our data showed that there is a difference in the 
extent of DNA damage between HPV-transfected and -positive cell lines. 
We observed that ECT1/E6 E7 cells showed a much higher level of CSC-
induced oxidative damage compared to CaSki cells. One possible 
explanation is that the immortalized cells may be more prone to oxidative 
injury. This is in agreement with the study of Wilmer and coworkers who 
showed that cystinotic cell lines immortalized with HPV E6/E7 appear to 
show increased oxidative stress and altered redox status compared to 
control cells [172]. C33A cells showed the lowest level of 8-oxodG in 
response to CSC compared with ECT1/E6 E7 and CaSki cells. This 
observation might be due to the lack of synergistic impact of HPV on CSC-
induced oxidative DNA damage in C33A cells, which are devoid of HPV 
sequences. This contrasts with the studies of Wei et al. that showed the 
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DNA damage and mutation were decreased in cells harboring high risk 
HPV infection in response to nitric oxide, a source of oxidative damage 
resulting from cigarette smoking [173]. Nonetheless, we speculate that 
carcinogenic HPV induces a higher burden of oxidative DNA damage in 
cervical cells, which may directly point to the critical role of HPV in CSC-
induced oxidative injury. 
Oxidative DNA damage has been shown to trigger activation of 
several cellular processes, such as apoptosis and cell cycle checkpoint, in 
order to maintain cellular homeostasis [174]. The current study 
demonstrates that in addition to increasing 8-oxodG lesion levels in 
cervical cells, CSC can induce a dose-dependent increase in apoptosis in 
ECT1/E6 E7 cells with an arrest at GoIG 1 phase of cell cycle. However, 
CSC-induced apoptosis occurred in small percentages of cells. The 
remaining surviving cells may undergo proliferation, which, in turn, 
compromises the genomic integrity of the cells by increasing the 
possibilities of accumulation of DNA mutations. Similar observation was 
reported by Liu et al. on the effect of cigarette smoke extract on human 
bronchial epithelial cells [175]. The fact that almost 50% of cells resist the 
cell cycle arrest as shown in this study may also playa role in genomic 
instability; these cells have altered function, which may eventually 
contribute to cervical pathogenesis. These results also suggest that DNA 
repair processes can be initiated in response to DNA damage by cigarette 
smoke since many cells undergo oxidative DNA damage, apoptotic 
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activation pathway and cell cycle checkpoint but survive; these cells may 
harbor genomic instability. 
Intriguingly, 8-oxodG removal was most efficient (93%) in HPV-
positive CaSki cells compared to HPV-negative C33A, which did not 
reveal any significant removal of the oxidative DNA damage up to 48 h. 
Different scenarios could be considered to explain the differences in the 
responses of HPV-positive and -negative cell lines to CSC-induced 
oxidative DNA damage in the present study. One possibility may be due to 
the residual activity of p53 that has been reported in cervical cancer cells 
[108-109]; CaSki cells have the highest basal p53 activity [107]. Our data 
support these findings that basal p53 activity exists in CaSki cells, and to 
some extent in ECT1/E6 E7 cells, despite the co-expression of the viral E6 
oncogene. However, C33A, containing mutant p53 genes lacked the p53-
mediated response to DNA damage [108]. In concordance with the notion 
that the p53 protein is functional in HPV-infected cells, we observed that 
oxidative DNA damage was removed most efficiently in the following 
order: CaSki > ECT1/E6 E7 > C33A. These findings suggest that the 
presence of residual p53 activity in HPV-infected cells may have a role in 
removal of oxidative DNA damage. 
Our data clearly showed that expression of p53 differed between 
HPV-positive and -negative cervical cells in response to CSC-induced 
DNA damage. The data revealed that p53 expression was not altered in 
C33A. In contrast, in HPV-positive cells, p53 expression was higher during 
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the removal phase of the oxidative DNA damage. These findings are 
congruent with the results of several studies indicating the existence of 
residual wild-type p53 activity in cervical carcinoma cells [108-109]. The 
authors showed HPV-positive cancer cells contained enough p53 to 
elucidate the activity of a downstream p53 upon exposure to genotoxic 
stress. On the other hand, Kessis et al [176] showed that DNA damage 
could not stimulate p53-dependant activities in HPV 16 E6-expressing 
cells. This finding was due primarily to an augmented E6 response 
generated by constitutive promoters. The observation that the HPV-
negative cells could achieve the same level of DNA repair after 72 h post-
exposure along with their unaltered p53 expression may thus provide 
possible evidence for the existence of the p53-independent repair pathway 
[168]. This is due to the inactivation of p53 by the mutation of the gene in 
these cells [99, 177]. The precise mechanistic pathway responsible for the 
delayed repair in C33A and HPV-transfected cells as compared to HPV-
positive cells requires further investigation. 
The notion that p53 plays a role in BER is supported by the 
observation that the cell extracts expressing wild-type p53 exhibit an 
enhanced BER response, which was later abolished upon p53 depletion 
[167]. Further, a study by Zhou et al. has suggested that p53 is directly 
involved in BER, which might be due to its dual functions: as a responder 
of DNA damage and also as an active participant in repairing the induced 
damage [178]. These studies directly support our findings that p53 may 
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have played an integral role in removal of the CSC-induced oxidative 
damage in the cells expressing wild-type p53 despite the co-expression of 
the E6 oncogene. 
It is of interest to note that oxidative DNA damage was sharply 
increased in the first 24 h after withdrawal of CSC in HPV-transfected and 
-negative cells. A similar observation of a transient increase of oxidative 
DNA damage following cessation of smoke exposure in the lung of A/J 
mice has been made [83]. This finding could be explained by the 
heterogeneous nature of CSC, including carcinogens, promoters, tumor 
inhibitors, and DNA repair inhibitors [62, 179]. Thus, the transient increase 
in oxidative DNA damage detected in our studies could possibly be due to 
the effect of DNA repair inhibitors in conjunction with free radical-
producing quinones/semiquiniones in CSC. 
To conclude, we have demonstrated that CSC-induced oxidative 
DNA damage is more pronounced in HPV infected cells. We also have 
shown that 8-oxodG was removed almost completely 72 h post-exposure 
in all the cervical cell lines tested, regardless of HPV status. The similarity. 
of responses to CSC-induced oxidative DNA damage between cell lines 
expressing mutant p53 or the E6 oncoprotein suggests that interaction of 
E6 and p53 may be functionally comparable to p53 mutations. These 
observations lead us to presume the possibility of both p53-dependent 
and -independent DNA repair pathways in our experimental setting. 
Though CSC-induced oxidative DNA damage was eventually removed in 
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all the cells, the possibility of error-prone DNA repair, however, cannot be 
ruled out. Chakravarti et al. have shown that DB[a,~P-induced DNA 
depurinating lesions are subject to error-prone excision repair in pre-S-
phase cells, which generates heteroduplex mutations in the H-ras gene 
[180]. The error-prone DNA repair may render cells susceptible to the 
accumulation of genetic mutations associated with carcinogenesis and 
tumor progression. 
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Figure 3.1: Cigarette smoke condensate (CSC)-induced 8-oxodG lesion 
in ECT1/E6 E7. Cells treated with vehicle for 24 h (a) and 72 h (c) and 
CSC (12 Ilg/ml) for 24 h (b) and 72 h (d) were stained with Alexa Flour 
488-Conjugated anti-8-0HdG and quantified by flow cytometry. e and f 
represent dose- and time-response to CSC-induced oxidative DNA 
damage as measured by 8-oxodG total fluorescent intensity. Data 
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Figure 3.2: Removal of cigarette smoke condensate (CSC)-induced 
oxidative DNA damage in ECT1/E6 E7 (a), CaSki (b), and C33A (c) cells: 
Cells treated with vehicle (i) and CSC (12 Ilg/ml) (ii) for 72 h, and 72 h 
post csc exposure (iii) were stained with Alexa Flour 488-Conjugated 
anti-8-0HdG, and the images were acquired by multispectral imaging flow 
cytometry. (iv) denotes kinetics of removal of CSC-induced oxidative DNA 
damage: rhombus (0) , square (4), triangle (8), and circle (12) Ilg/ml CSC. 
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Figure 3.3: Assessment of p53 expression in different human cervical 
cells. ECT1/E6 E7 (a), CaSki (b), and C33A (c) cells were treated with 
cigarette smoke condensate (CSC) (12 Ilg/ml) for 72 h to induce the 8-
oxodG lesion. Then, cells were freed of the residual CSC and further 
incubated for 72 h for repair of oxidative DNA damage to occur, stained 
with Alexa Flour 488-conjugated anti-p53 antibody and quantified by flow 
cytometry. Data represent mean ± SO of three independent experiments 
(p < 0.04). 
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Figure 3.4: Effects of cigarette smoke condensate (CSC) on cell cycle 
distribution in HPV-transfected cervical cells. Flow cytometry analysis 
using propidium iodide staining to determine cell cycle phase distribution 
following vehicle (a), and CSC (12 Ilg/ml) (b) treatment for 24 h. 
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Figure 3.5: Cigarette smoke condensate (CSC)-induced apoptosis in 
HPV-transfected cells. Apoptosis was induced with 0 (a) and 12 Ilg/ml 
CSC (b) for 24 h and cells were stained with Annexin V-FITC and 
quantified by flow cytometry. Left and right square boxes of each panel 
represent the apoptotic and live cell populations, respectively. 
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CHAPTER IV 
THE INTERPLAY OF CIGARETTE SMOKING AND HPV INFECTION IN 
HUMAN VAGINAL CELLS: AN EX VIVO STUDY 
70 
A. Introduction 
Vaginal tumors account for an incidence of approximately 1-2% of 
lower genital tract malignancies [3, 71] The etiology of vaginal cancer 
mainly remains equivocal. Nevertheless, there are a few population-based 
case-control studies for the etiology of this rare abnormality [66-68, 72]. 
These studies reveal that the majority of vaginal cancers have common 
risk factors with cervical cancers; the most reported shared risk factor 
among women with cervical and vaginal tumors is infection with cancer-
associated human papillomavirus (HPV) types. High-risk HPV prevalence 
is comparable in cervical and vaginal samples [14], which, in turn, signifies 
that both tissues can retain cancer-associated HPV infection. However, 
cervical abnormalities are far more common compared with vaginal 
tumors [181]. The possible justification for the infrequent occurrence of 
vaginal cancer, despite infection with cancer-associated HPV, may be due 
to the different transformation potential of the virus in cervical and vaginal 
tissues [182]. 
Other epidemiological and etiological variables associated with 
cervical cancer have also been reported to be pertinent to the etiology of 
vaginal tumors, such as cigarette smoking [66]. Although conflicting data 
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exist on the role of smoking in the development and progression of HPV 
lesions in vaginal cells [66, 183-184], the exact mechanism by which 
cigarette smoking exerts its cytotoxic effects is not fully understood. 
Cigarette smoke is a heterogeneous mixture of approximately 
5,000 chemical compounds, of which several dozen are carcinogens, co-
carcinogens, mutagens and tumor promoters [116], including polycyclic 
aromatic hydrocarbons (PAHs), N-nitrosamines, inorganic and organic 
compounds [118, 185]. It has been reported that cigarette smoke-induced 
genotoxicity results in induction of DNA damage, such as double-strand 
breaks (DSBs) [58]. Single-strand breaks are considered an indicator of 
early damage [125] and they are intermediate processing products of DNA 
damage, which, if left unrepaired, may develop into mutagenic and lethal 
double-strand breaks [143]. DSBs are a more disruptive form of strand 
break since they can either lead to cell death or genetic instability, if left 
unrepaired, or they may cause neoplastic progression if the repair process 
is compromised [128,144]. 
Previous studies with human HPV-transfected Ect1/E6 E7 cervical 
cells suggested that cigarette smoke-mediated DNA DSBs are highly 
persistent, which may lead to increased mutation and ultimately higher 
cancer risk [170]. Hence, the effect of cigarette smoking on human vaginal 
cells warrants an investigation. The aim of this study was to investigate 
whether cigarette smoking, given the infection with high risk HPV types, 
leads to detectable DNA damage in vaginal cells. In order to examine this, 
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we employed single cell gel electrophoresis (SCGE), also known as the 
comet assay. That is a sensitive technique to detect DNA strand breaks at 
the single cell level [131, 186]. 
B. Materials and Methods 
1. Study population 
Eligible patients (n = 100) who visited the Gynecologic Oncology 
Clinic at James Graham Brown Cancer Center and University of Louisville 
Ob/Gyn Colposcopy Clinic during 2007 through 2009 participated in the 
study (Table 4.1). Each patient was informed about the study protocol at 
the time of her visit and given a written informed consent prior to the 
study. Patients answered an NIH-approved questionnaire about their 
medical history and smoking habits. The patients' high-risk HPV status 
was obtained from hospital records and/or a detailed questionnaire. The 
protocol, consent form and questionnaire for this study were approved by 
the Institutional Review Board at the University of Louisville. Women who 
were pregnant and/or receiving radiation/chemotherapy in the last year 
prior to the time of their visit were excluded from the study. Thus, 76 
subjects who satisfied the exclusion criteria were included. The study was 
conducted in a blinded fashion. 
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2. Materials 
Keratinocyte serum-free medium (K-SFM), bovine pituitary extract 
(BPE), epithelial growth factor (EGF), penicillin/streptomycin, 
trypsin/EDTA solution and low-melting agarose were from Invitrogen 
(Carlsbad, CA, USA); sodium N-Iauroyl sarcosine, DMSO, Tris and 
spermine were from Sigma Aldrich (St. Louis, MO, USA); proteinase K 
was from Roche (Switzerland); EDTA was from Mallinckrodt Chemicals 
(Hazelwood, MO, USA). 
3. Collection of human specimens 
A Dacron ™ cervical swab was used to obtain vaginal material from 
the lateral vaginal wall. Swabs were immediately placed in a 5-ml solution 
consisting of K-SFM pre supplemented with 0.3% BPE, 0.1 ng/ml EGF, 
0.4 mM CaC12,1 % penicillin and streptomycin at 4°C for up to 2h. 
4. HPV status 
The assessment was made based on either the HPV testing or the 
Pap results done at the time of the visit. In case HPV testing was not 
done, the Pap results of low- grade squamous intraepithelial lesion 
(LGSIL) or high squamous intraepithelial lesion (HGSIL) were classified as 
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HPV positive. The final decision on the HPV status of each participant was 
confirmed by the Gynecologic Oncologist, Dr. Lynn Parker. 
5. Smoking status 
Information on the smoking history of the patients was obtained 
from the questionnaires. Patients were characterized to two broad 
categories: those who currently or formerly smoked (ever smoker) and 
those who did not smoke (never smoker). Thus, there were 49 ever 
smokers (28 current and 21 ex-smokers) and 27 never smokers. 
6. Comet assay 
DNA DSBs were detected by neutral comet assay, as described 
previously [131, 170, 186]. Briefly, vaginal samples were centrifuged, 
washed with PBS and processed immediately. 100,000 cells per slide 
were embedded in 1 % low-melting agarose on frosted microscopic glass 
slides. The cells were subsequently lysed (1.25 M NaCI, 0.1 % sodium N-
lauroyl sarcosine, 50 mM Na-EDTA, 100 mM Tris-HCI, pH 10), digested 
with proteinase K (1.25 M NaCI, 5 mM EDTA, 5 mM Tris-HCI, 0.5 mg/ml 
proteinase K, pH 10) and the DNA was precipitated (50% ethanol, 1 mg/ml 
spermine, 20 mM Tris-HCI, pH 7.4). DNA was unwound using a 
neutralizing buffer (500 mM Na-EDTA, 0.2% DMSO, 500 mM NaCI, 100 
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mM Tris-HCI, pH 9.0) and then electrophoresed in the same buffer (26 V; 
250 mA at 4°C). After staining the cells with ethidium bromide, comets 
were visualized using a light microscope attached to a digital camera with 
510 excitation and 590 emission filters. The images were analyzed using 
the software Comet Assay IV (Perspective Instruments, Haverhill, UK). A 
total of 50 cells per slide and 2 slides per sample were scored for tail 
length (TL) and tail moment (TM) as described before [170]. Tail length is 
defined as the distance between the center of the comet head and the end 
of the tail. Tail moment is often considered a more significant indicator of 
DNA damage since they refer both to the distance of DNA migration and 
the amount of DNA in the tail [136]. The higher the values of tail length 
and tail moment, as computed by the software, the higher the level of DNA 
damage. 
c. Statistical analysis 
The analysis was conducted to examine the influence of age, HPV 
infection, smoking and disease status as individual variables and multi-
variables on the extent of DNA double-strand breaks using the 
generalized linear regression model [187]. The mean, standard deviation 
(SO), median, minimum and maximum along with 95% confidence 
intervals for TL and TM were computed within each level of the categorical 
variables. The p-values were computed using the Wilcoxon rank-sum test 
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between HPV positive and negative subjects, ever and never smokers, 
and between old (>36 years) and young (:536 years) patients for TL and 
TM. We further performed the subset analyses on smokers and non-
smokers based on their HPV status. Age was grouped using a median 
cut-off and non-parametric test was used. Furthermore, we performed the 
multi-variable analysis to estimate the simultaneous effects of the HPV 
and smoking covariates on TL and TM. We have observed very strong 
association between HPV status and disease status (p <0.001). Therefore, 
age, HPV infection and smoking status were analyzed using PROC GLM 
[187] in SAS system (v9), where age was considered as both a categorical 
and continuous variable. 
D. Results 
1. The influence of HPV infection on induction of DNA double-
strand breaks 
We investigated the potential role of cancer-associated HPV types 
in inducing DNA DSBs. The percentage of women enrolled in this study 
with high-risk HPV DNA was higher (n = 46; 60.5%) compared with 
women who were reported to be negative for the virus (n = 30; 39.5%). 
Two most common types of DNA strand break measurements were 
recorded: tail length and tail moment. The mean tail length for those who 
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were infected with HPV was significantly (p < 0.001) lower (31.2 +/- 18.7 
11m) compared with women who were HPV negative (61.7 +/- 22.6 11m) 
(Figure 4.1, Table 4.2). These data indicate that those with HPV infection 
showed a lower degree of DNA damage compared to those who did not 
have HPV DNA. Similar results were found for tail moment (HPV positive, 
2.4 +/- 2.8 AU; HPV negative, 8.7 +/- 4.9 AU) demonstrating the significant 
(p < 0.001) inverse association between HPV infection and extent of 
double-strand DNA breaks in the studied population. 
2. DNA double-strand breaks induced by cigarette smoking 
We examined whether DNA strand breaks correlated with the 
smoking status of the study population. The study group was (n = 76) 
comprised of the population who never smoked (n = 27; 35.5%) and ever 
smokers (either currently or formerly) (n = 49; 64.5%). The clinical and 
general characteristics of the study population are presented in Table 4.1. 
The mean tail length for never smokers was 57.7 +/- 24.5 11m. The ever 
smokers group had a mean tail length of 35.3 11m +/- 21.9. We found a 
significant inverse association between smoking status and tail length (p < 
0.001) indicating that those who never smoked have, on average, a higher 
degree of DNA DSBs compared with individuals who had reported as 
smokers (Figure 4.1; 4.2, Table 4.2). Similarly, mean tail moment was 7.5 
+/- 5.5 AU among never smokers compared with 3.4 +/- 3.7 AU for those 
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who smoked. This finding signifies that those who never smoked showed 
a higher extent of DNA strand breaks (p < 0.001). 
3. The effect of age on DNA double-strand breaks 
In order to understand the effect of age on DNA damage, analysis 
was carried out taking into account the age as both a continuous and 
categorical variable (Table 4.2). Forty patients (52.6%) were less than or 
equal to the median age of 36 and 36 patients (47.4%) were above the 
median age. There were significantly higher DNA DSBs in older women 
compared with younger women: mean TL of 61.2 +/- 22.5 versus 27.1 +/-
13.9 11m (p < 0.001) and mean TM of 8.3 +/- 5.0 AU versus 1.8 +/- 1.6 AU 
(p < 0.001). 
4. The interaction between HPV infection and smoking status 
Subjects with HPV-positive and -negative status were further 
categorized based on their smoking status as summarized in Table 4.3. 
Ever-smoker and HPV-positive women (n = 32) had significantly lower 
mean TL compared to never-smoker and HPV-positive individuals (n = 14) 
(23.9 ± 11.3 11m versus 48.0 ± 21.8 11m; p < 0.001). This inverse 
association was also observed in mean TM (Ever smoker and HPV 
positive, 1.4 ± 1.0 AU versus never smoker and HPV positive, 4.7 ± 4.1 
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AU) (Figure 4.3). A non-significant association with TL (p = 0.258) and TM 
(p = 0.079) was observed among smokers who were negative for HPV 
infection. 
5. The interaction among HPV infection, cigarette smoking and 
age 
We examined the influence of HPV infection, smoking status and 
age on induction of DNA DSBs in the study population (Table 4.4). Age as 
either a categorical (:::;36 and >36) or continuous variable showed a strong 
association when using the multivariable generalized linear regression 
model. Significant association was observed between TL and HPV for age 
as categorical (p = 0.019) and as continuous (p = 0.034) variable. This 
finding indicates that women with HPV infection had a lower mean TL 
(31.2 ± 18.7 11m) compared to HPV negative individuals (61.7 ± 22.6 11m) 
regardless of their age. Similarly, TM and HPV status conferred a 
significant association (p = 0.002) for age as both categorical and 
continuous variable, indicating a lower TM (2.4 ± 2.8 AU) in women with 
HPV infection compared with those who were HPV negative (8.7 ± 4.9 
AU). The smoking status was significantly correlated with TL (57.7 ± 24.5 
11m vs. 35.3 ± 21.9 11m) and TM (7.5 ± 5.5 AU vs. 3.4 ± 3.7 AU) for age as 
categorical (p < 0.001) and continuous variable (p = 0.003). These 
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findings suggest the negative correlation between smoking status and 
DNA DSBs regardless of age. 
E. Discussion 
We examined the interplay of cigarette smoking and high-risk HPV 
infection on the DNA integrity of vaginal cells. Based on our experimental 
findings, we confirmed that the levels of DNA double-strand breaks are 
inversely correlated with both smoking and HPV status. This observation 
suggests that the vaginal epithelium may have a different transformational 
ability by HPV infection. 
About 17 to 20% of the individuals who were approached to take 
part in the study were not considered based on the defined exclusion 
criteria: i) radiation/chemotherapy in a year prior to the time of visit, and ii) 
current pregnancy. The rationale for excluding individuals undergoing 
radiation/chemotherapy treatment was based on an earlier study reporting 
that radiation treatment resulted in 5- to 6-fold increase in DNA adduct 
levels, detected by 32P-postlabeling, compared with the initial level [188]. 
Pregnant women were excluded from the study due to an observed higher 
incidence of HPV infections [189] and a more rapid progression of cervical 
dysplastic lesions to carcinoma compared to non-pregnant women [190]. 
Moreover, progesterone induces the expression of several anogenital 
HPV genes, including HPV 16, through hormone response elements 
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within regulatory regions of the viral genome [191-192]. The choice of 
location for collecting the vaginal specimens is one of the strengths of our 
study. We collected the vaginal specimens from the lateral vaginal wall to 
minimize the possible contamination by cervical and metaplastic epithelial 
cells. This site-specific specimen collection was further validated by 
microscopic evaluation of the mature squamous cells encompassing the 
vaginal epithelium. However, we cannot rule out the possibility of sloughed 
cervical cells in those vaginal samples. Nonetheless, the great majority of 
the cells were mature squamous types and the homogeneous nature of 
the collected samples was cytologically confirmed. 
One of the intriguing findings that emerged from our study was that 
HPV infection showed an inverse relation with the extent of DNA strand 
breaks in the studied population. Considering that a link between high-risk 
HPV and Vaginal Intraepithelial Neoplasia has been reported [193], the 
induction of DNA damage by the virus is a logical hypothesis. Moreover, 
even though the natural histories of cervical and vaginal lesions appear 
similar [194], neoplastic and invasive vaginal abnormalities are far less 
common than both cervical intraepithelial neoplasia and invasive cervical 
carcinoma [181]. This obvious discrepancy may be explained by 
considering two facts. One is that the vagina lacks a squamo-columnar 
junction, known as transformation zone [13]. The importance of the 
transformation zone is evident by the fact that most of the dysplasia 
caused by persistent HPV infection frequently arises, for unknown 
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reasons, in areas where two different types of epithelium merge such as 
that occurring in the cervix, anus and oro-pharynx [195]. It has also been 
reported that the transformation zone is more sensitive to HPV infection 
[14] since the squamous metaplastic cells - constituents of the 
transformation zone - are needed to support the carcinogenic alteration by 
high-risk HPV [14]. Secondly, the discrepancy may also be explained by 
the variable manifestations of HPV infection in the vagina compared to 
that in the cervix, even though the virus infects vagina and cervix with the 
same frequency [196]. HPV replication in lytic infection is more efficient 
and results in producing progeny virions, which eventually destroy the 
infected vaginal cells. In contrast, HPV replicates less efficiently in the 
cervix and tends to remain within the cells as latent infection, a 
phenomenon involved in persistence of the infection [182]. 
Even though persistent high-risk HPV infections account for a great 
majority of cervical cancers [26, 197], cell-mediated immunity plays a 
significant role in clearance of the infection within 1-2 years of exposure 
[198]. There are, however, no data reported on role of HPV persistence on 
DNA damage particularly in vaginal walls. Based on our experimental data 
indicating decreased level of DSBs in HPV-positive individuals, we deduce 
that vaginal cells may be more resistant to the DNA damaging effect of 
HPV infection. This speculation was partly derived from the fact that HPV 
has the ability to hinder host defenses by several means, such as the lack 
of viral-induced cell death in keratinocytes and downregulation of the 
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expression of interferon [198]. As part of the HPV infectious cycle, which 
depends on the differentiation status of the target cell, the virus infects 
primitive keratinocytes; the expression of viral proteins and viral assembly 
occur at much higher level in the superficial squamous cells that are 
terminally differentiated [199]. These differentiated keratinocytes that 
mainly cover the vaginal wall are intended for death and desquamation. 
Therefore, HPV replication, assembly and particle release do not trigger 
any cytolysis, and therefore a immune response due to lack of 
inflammatory reaction [198]. A limitation of the study is that the HPV status 
was based on the detection of the collective presence of carcinogenic 
HPV types instead of the individual HPV genotypes. Stratification of the 
patients based on specific HPV genotypes may provide further insights 
into the complex interrelation of smoking and progression of HPV infection 
in vaginal carcinogenesis. The HPV testing used for this study, however, 
employed a combination of DNA probes to test for high-risk viral types, 
including HPV 16, which is the most prevalent high-risk HPV strongly 
associated with vaginal carcinogenicity [67, 200-201]. 
Based on significant increase in DNA DSBs in HPV-negative 
individuals, we infer that, in our study population, the extent of DNA 
damage is independent of HPV infection. However, DNA strand breaks 
were the only measured endpoint used in this study. Investigation of other 
forms of HPV-associated damage, including chromosomal instabilities 
[202] is warranted. Other pre-disposing factors, such as history of cervical 
84 
and/or vaginal abnormalities, chronic irritation [3] and cigarette smoking 
[68] may have an impact on DNA integrity of vaginal cells. 
We have clearly shown that the extent of DNA DSBs increases as a 
function of age. Our finding is congruent with the studies of Singh et al. 
and Morris et al. who demonstrated an increase in DNA strand breaks with 
age in human sperm [132, 203]. Additionally, age-related differences have 
been reported among individuals diagnosed with cervical cancers 
compared to those with vaginal cancers [71]. Carcinoma of vagina mainly 
occurs in elderly women (~ 60 years) [71, 204-206]. This finding signifies 
the age-associated alterations in DNA structure, such as double-strand 
breaks [132] that may, in turn, attribute to genetic instability and ultimately 
vaginal carcinogenesis. The extent of double-strand DNA breaks 
increases with age of the population examined, which implies that older 
women are at higher risk for accumUlation of mutation and genetic 
instability. Thus, the relevance of our findings to public health in identifying 
high-risk population is significant. 
Our analysis demonstrated a significant inverse correlation 
between DNA strand breaks and smoking habit. Data on smoking was 
obtained by self-reporting smoking history. However, the smoking history 
was obtained prior to medical examination, which minimizes the chance of 
reporting inaccurate smoking habit (underestimation or denial) among the 
participated women in the study. Furthermore, measurement of 
biochemical parameters such as cotinine, thiocyanate and carbon 
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monoxide are not considered to be impeccable due to several factors, 
such as short half-life of smoking by-products in the body [207]. Self-
reporting smoking history, when compared with biochemical validation, 
has been reported to have sensitivity and specificity of above 85% [207]. 
Few studies, however, have reported a positive association 
between cigarette smoking and vaginal abnormalities [67-70]. These 
studies were based on an epidemiological association that appears to link 
cigarette smoking with vaginal cancer. In contrast, in the current study, 
DNA strand breaks, as a biological endpoint, was measured to provide 
insights into the mechanistic effect of the cigarette smoking on the etiology 
of vaginal cancer. We found no positive correlation between smoking and 
vaginal abnormalities. In contrast, two other studies found a non-
significant epidemiological association with smoking in vaginal carcinoma 
[71-72]. Furthermore, oxidative DNA damage caused by treatment with 
cigarette smoke condensate were repaired in HPV-transfected, HPV-
positive and HPV-negative human cervical cancer cells with equal 
efficiency, which may be attributed to p53-dependent and -independent 
DNA repair pathways (Chapter III). We infer from this and other studies, 
that cigarette smoke exposure can alter the mechanisms of gene 
expression or their functions, which may, in turn, have a variable effect on 
DNA integrity. Equally important, we cannot overlook the confounding 
cumulative effects of polymorph isms in DNA repair genes, the 
heterogeneous nature of cigarette smoke constituents, and exposure to 
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other environmental factors in evaluating the influence of smoking on 
HPV-mediated vaginal tumorigenesis. 
The role that cigarette smoking plays in the development and/or 
progression of HPV infection is convoluted and not yet entirely 
understood. Our data derived from the ex-vivo study clearly showed an 
inverse relationship between the interaction of cigarette smoking and HPV 
infection in the induction of DNA strand breaks regardless of age. These 
findings are not in aggreement with the results of Sellors et al., who 
reported that smoking was not a risk factor for HPV infection or 
persistence [184]. On the contrary, in several studies elevated levels of 
tobacco related carcinogens such as benzo[a]pyrene and nitrosamine 4-
(methylnitrosamino )-1-(3-pyridyl)-1-butanone (N NK) were identified in 
cervical mucosa of cigarette smokers compared to non-smokers [53, 55, 
57]. It is worth noting that the systemic effect of tobacco smoke on vaginal 
epithelium may not manifest itself by DNA DSBs, the only endpoint 
investigated in this study. Importantly, the scarcity of literature on the 
biological effects of cigarette smoke on vaginal epithelium provide us with 
a challenging and unique prospect to caution ourselves in making a 
generalized statement from a public health perspective. 
In conclusion, we found that HPV infection, cigarette smoking and 
the interaction between the two have a significant inverse relation with 
DNA DSBs detected in vaginal epithelium of the population studied. To the 
best of our knowledge, there are no other studies that assessed any DNA 
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damage endpoint in vaginal cells in relation to smoking and HPV infection 
status. Lack of DNA damage in HPV-positive patients may partially explain 
the relatively lower incidence of vaginal cancers compared to cervical 
cancers subsequent to HPV infection. Even though the overall conclusion 
is restricted by the small sample size, the highly differentiated nature of 
vaginal squamous cells and lack of persistence of HPV infection may 
partly explain the negative association between the investigated 
parameters. Previous findings are supportive of this notion where a 
reduction in DNA strand breaks of human cervical cancer cells was 
observed by ellagic acid [170], a polyphenol present in significant amounts 
in berries. Therefore, the higher degree of DNA damage in older women 
may signify the benefits of consumption of foods rich in antioxidants. From 
an etiological point of view, further studies with broader scope and larger 
sample size are required to elucidate the impact of cigarette smoking as a 
cofactor in vaginal carcinogenesis. 
88 
Figure. 4.1: Representative comet assay images. Panel (A) depicts 
intact nuclei in a HPV positive individual. Panel (8) shows DNA double-
strand breaks in a HPV negative participant. Panels (C) and (D) 
represent double-strand breaks in DNA of never and ever smokers, 
respectively. 
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Figure. 4.2: Scattered plot presentation of the OSBs in the studied 
population. Panels represent the distribution of (A) tail length and (B) 
tail moment, respectively in HPV-positive and -negative individuals. 
Panels (C) and (0) depict the distribution of tail length and moment 
among ever- and never-smokers (p < 0.001). Lines signify the mean. 
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Figure 4.3: Correlation between HPV infections and smoking status 
presented by scattered plot in the studied population. Panel (A) represents 
the distribution of tail length (A 1) and tail moment (A2) in HPV positive 
women. Panel (8) depicts the distribution of tail length (81) and tail 
moment (82) in HPV negative individuals with respect to smoking status 
(p < 0.001). Lines signify the mean. 
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Table 4.2. Comet Assay Measured in the Vaginal Cells of the Subjects 
Numbers{%l Mean TL:l:SO 95% CI PValues MeanTM :I: so 95% CI PValues 
HPV Infection 
Positive 46 (61 ) 31 .2:1:18.7 25.2 - 37.2 <0.001 2.4:1: 2.8 1.3-3.5 <0.001 
Negative 30 (39) 61 .7:1: 22 .6 54.3 - 69 .1 8.7:1: 4.9 7.3 -10.0 
Smoking Status 
Never 27 (36) 57.7:1: 24.5 48.9 - 66.5 <0.001 7.5:1:5.5 5.8 - 9.3 0.001 




S36(% ) 40 (52.6) 27.1:1:13.9 22.8 - 31.4 <0.001 1.8:1: 1.6 1.3-2.3 <0.001 
>36(%) 36 (47.4) 61.2:1: 22.5 53.9:1: 68.6 8.3 :1:5.0 6.6 - 9.9 
Age 
Continuous <0.001 <0.001 
Est. ± SE 1.07:1: 0.12 0.20:1: 0.02 
Table 4.3. Comet Assay Measured in the Vaginal Cells of the Subjects Stratified for HPV 
and Smoking Status 
Numbers{%} MeanTL:t SO PValue MeanTM :t SO PValue 
HPV Positive 
Never 14 (18) 36.9± 21.9 <0.001 4.7±4.1 <0.001 
\0 Ever 32 (42) 23.9 ± 11.3 1.4 ± 1.0 
~ 
HPV Negative 
Never 13 (17) 68 .1 ± 23.6 0.258 10.7 ± 5.4 0 .079 
Ever 17 (22) 56.8±21.1 7.2 ± 4.0 
Table 4.4. Generalized Linear Regression Model on Age, Smoking and HPV Status 
Dependent Intercept HPV Positive Ever SmokinQ 
Est. PValue Est. PValue Est. PValue 
TL 59.56 <0.001 -13.015 0.019 -15 .318 <0.001 
\0 
Age as Categorical 
VI TM 7.2 <0.001 -3.419 0.002 -2 .852 <0.001 
TL 16.93 0.0155 -11 .312 0 .034 -12.582 0 .003 
Age as Continuous 
TM 0.61 0 .644 -3.298 0.002 -2.468 0.003 
CHAPTER V 
SUMMARY AND GENERAL DISCUSSION 
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A. Major Findings 
The experiments performed in Chapter II of this dissertation were 
designed to test the hypothesis that cigarette smoke is a major cofactor in 
cervical carcinogenesis. We examined the role of CSC in inducing DNA 
damage in a HPV-transfected human cervical cell line (ECT1/E6 E7). 
Additionally, the effect of ellagic acid, a potent antioxidant protective 
against the CSC-induced oxidative DNA damage was examined. 
Experiments described in Chapter III were built on results of Chapter II, 
and examine the role of CSC in induction and removal of oxidative DNA 
damage. The selection of a human cervical cancer cell line was expanded 
to include both HPV-positive (CaSki) and -negative cervical cancer cells 
(C33A) in addition to HPV-transfected cells in order to further investigate 
the effect of CSC on the induction of oxidative DNA damage in association 
with HPV. Chapter IV is an ex vivo study, which focuses on examining the 
role of cigarette smoking and high risk HPV infection in human vaginal 
cells. Specific findings of these chapters are described below. 
97 
1. Cigarette smoke condensate can induce DNA strand breaks 
As noted in Chapter II, cigarette smoking is one of the major risk 
factors in HPV-mediated cervical cancer, since it has been consistently 
linked with the progression of cervical neoplasia [15]. In fact, female 
smokers are at two times higher risk of developing cervical cancer than 
non-smokers [208]. The mechanism of smoking in mediating neoplastic 
transformation of cervical cells, however, remains inconclusive and was 
the main question of this chapter. Experiments were designed to 
investigate CSC-induced DNA damage and subsequent repair in HPV-
immortalized cervical cells. 
First, a time- and dose-response of CSC on human ECT1/E6 E7 
was determined. Next, we employed single-cell gel electrophoresis, also 
known as the comet assay, to further examine the role of CSC in the 
induction of DNA single- (SSBs) and double-strand breaks (DSBs). To 
investigate the ability of the cells to repair CSC-induced DNA strand 
breaks, the residual DNA damage subsequent to removal of CSC was 
further determined by the comet assay. In order to investigate if free 
radical-producing constituents of CSC are the source of DNA damage, we 
examined the effect of an antioxidant, ellagic acid, in mitigating CSC-
induced DNA damage. 
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The major findings of this chapter are that CSC can induce DNA 
strand breaks in human HPV-transfected cells in a time- and dose-
dependent fashion. Equally important is the fact that our study reveals the 
inability of HPV-transfected cells to entirely repair CSC-induced DNA 
damage. Additionally, we have also demonstrated that oxidative stress 
may be the source of DNA damage caused by CSC. The data presented 
in this chapter suggest that persistent DNA strand breaks caused by the 
inability of the cells to remove the damage may result in accumulation of 
mutations leading to cancer [89]. These findings provide experimental 
evidences that support the previously reported epidemiological association 
between HPV Infection, cigarette smoking and cervical cancer 
development [46, 161]. 
2. Cigarette smoke condensate can induce oxidative DNA 
damage 
One of the findings of this dissertation is that CSC can be a source 
of oxidative stress (Chapter II), which serves as a building block to further 
investigate the effect of CSC in association with HPV infection in human 
cervical cancer cells (Chapter III). The rationale for the experiments 
designed in this chapter was based on the epidemiological and 
experimental findings that cigarette smoke or its components induce 
oxidative DNA damage [58], such as 8-oxo-7 ,8-dihydro-2'-
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deoxyguanosine (8-oxodG), which is highly mutagenic and carcinogenic 
[171]. In fact, the levels of oxidative base lesions were reported higher in 
smokers as compared to non-smokers [84-86]. Therefore, the goal of this 
chapter was to determine the effect of CSC on oxidative DNA damage 
formation and its removal from HPV-transfected (ECT1/E6 E7), HPV-
positive (CaSki) and HPV-negative (C33A) human ceNical cancer cells. 
We further investigated the cell cycle progression and apoptosis in the 
CSC-treated ECT1/E6 E7 cells as a standardized in vitro model [169] to 
further understand the effect of cigarette smoke-free radicals and ceNical 
carcinogenesis. 
In this chapter, the role of tumor suppressor p53 as a transcription 
factor and regulator of cell cycle arrest or apoptosis [93] was also 
examined. It appears that the inactivation of the normal function of p53 is 
a critical step in human ceNical carcinogenesis, which can be either 
caused by mutation, as in HPV-negative cell [166] or from complex 
formation with E6 oncoproteins in the case of HPV-positive ceNical cancer 
cells [97]. 
The major finding of this chapter is the first demonstration of 
oxidative DNA damage induced by cigarette smoke constituents and its 
repair in human ceNical cancer cells using multispectral imaging flow 
cytometry techniques. 
These data suggest that CSC-induced oxidative DNA damage is 
more pronounced in HPV-infected cells. Furthermore, we showed that 8-
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oxodG was removed almost completely 72 hours post-exposure in all 
cervical cell lines tested, regardless of HPV status. The similarity of 
responses to CSC-induced oxidative DNA damage between cell lines 
expressing mutant p53 or the E6 oncoprotein suggests that interaction of 
E6 and p53 may be functionally comparable to p53 mutations. These 
observations lead us to infer the possibility of both p53-dependent and -
independent DNA repair pathways in our experimental setting. Although 
CSC-induced oxidative DNA damage was eventually removed in all cells, 
the possibility of error-prone DNA repair, however, cannot be ruled out, 
which may lead to the accumulation of genetic mutations associated with 
carcinogenesis and tumor progression. 
3. Cigarette smoking and HPV infection act independently in 
vaginal cells 
Our in vitro findings (Chapters II and III) showed that CSC can 
induce DNA strand breaks as well as oxidative DNA damage. Moreover, 
our previous studies with human HPV-transfected ECT1/E6 E7 cervical 
cells suggested that cigarette smoke-mediated DNA DSBs are highly 
persistent, which may lead to increased mutation and ultimately higher 
cancer risk [170]. These findings led us to design an ex vivo study to 
further examine the role of cigarette smoking in human vaginal cells. The 
rationale behind the selection of vaginal cells, which are mature squamous 
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types, is to obtain a homogenous sample. The main objective of Chapter 
IV was to investigate whether cigarette smoking, given the infection with 
high-risk HPV types, would produce DNA damage in vaginal cells. 
Conflicting data exists on the role of smoking in the development 
and progression of HPV lesions in vaginal cells [66, 183-184]; the exact 
mechanism by which cigarette smoking exerts its cytotoxic effects is not 
fully understood. Results from Chapter IV of this dissertation directly 
support a negative association of smoking with vaginal abnormalities, 
which is in agreement with the two other studies, where a non-significant 
epidemiological relationship was found [71-72]. 
Age-related differences have been reported among individuals 
diagnosed with cervical cancer compared with those women with vaginal 
cancer [71]. Carcinoma of vagina mainly occurs in individuals older than 
60 years old [71, 204-206]. Our study showed a clear positive correlation 
between age and DSBs detected in vaginal cells of the studied population. 
This finding signifies the age-associated alterations in DNA structure, such 
as double-strand breaks [132] that may, in turn, attribute to genetic 
instability and ultimately vaginal carcinogenesis. 
The endpoint measured in this chapter was DNA DSBs, which can 
lead to chromosome translocation and cancer if improperly repaired, in 
addition to genetic instability and cell death if left unrepaired [128]. 
Considering that a link between high-risk HPV and Vaginal 
Intraepithelial Neoplasia has been reported [193], the induction of DNA 
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damage by the virus is a logical hypothesis. However, this hypothesis has 
not been directly tested, nor do our results support this theory. This may 
be due to the variable manifestations of HPV infection in the vagina 
compared to those in the cervix, even though the virus infects the vagina 
and cervix with the same frequency [196]. 
The most intriguing findings of this chapter is that the HPV infection 
and cigarette smoking have a significant inverse relation with DNA double-
strand breaks detected in vaginal epithelium of the population studied. 
Also, non-smokers with HPV infection tend to have more DNA DSBs 
compared to smokers, while there was no difference between smokers 
and non-smokers who had no HPV infection. There are no data reported 
as to DNA lesions in vaginal cells in relation to smoking and HPV infection 
status. This investigation suggests that vaginal cells differ in response to 
carcinogenic HPV infection and cigarette smoking, due to variety of 
factors, such as lytic versus latent HPV infection in vaginal and cervical 
cells, respectively, and resistance of highly differentiated vaginal epithelial 
cells to HPV. 
4. DNA Strand Breaks Detection 
The rational for detecting DNA double-strand breaks in vaginal cells 
was based on the finding that single-strand breaks were not detectable in 
64% of the vaginal samples, whereas only in 25% of the samples DNA 
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double-strand breaks were undetectable. There is no report in the 
literature indicating such observations. The samples with undetectable 
single- and/or double-strand breaks were categorized as "undefined". 
Table 5.1 depicts the summary of comet assay data for all 101 samples 
along with their representative images. 
B. Strengths and Weaknesses of this Dissertation 
1. Strengths 
This dissertation has many points of strength. First, it solidifies the 
role of cigarette smoke on the induction of DNA strand breaks and 
oxidative damage in human cervical cancer cells. Although there have 
been epidemiological and experimental findings on the causal role of 
cigarette smoke on DNA integrity of various organs, a biological endpoint 
demonstrating cytotoxic effects of cigarette smoke in human cervical 
cancer cells was provided by this work. Second, there has been 
speculation about the association of cigarette smoking, as an important 
cofactor, with high-risk HPV infection in cervical carcinogenesis. This 
study further supports the persistence of cigarette smoke-associated DNA 
damage in the presence of HPV infection, which may lead to accumulation 
of mutations in cervical cells and ultimately higher cancer risk. Third, 
literature on the biological effects of cigarette smoke on vaginal epithelium 
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is scarce. This work further contributed to the limited body of knowledge in 
understanding the interplay of cigarette smoking and HPV infection in an 
unprecedented ex vivo study. This work also suggests that cigarette 
smoking and HPV infection have a significant inverse relation with DNA 
double-strand breaks detected in vaginal epithelium of the studied 
population. 
Furthermore, the extent of double-strand DNA breaks increases 
with age of the population examined, which is suggestive that older 
women might be at higher risk for accumulation of mutation and genetic 
instability. Therefore, the relevance of our findings to public health in 
identifying high-risk population is significant. 
From a technical standpoint, the strength of this work was using a 
cell-based analysis known as the comet assay. It is a sensitive technique 
used to detect DNA strand breaks as well as assess DNA repair kinetics 
at the single-cell level [125, 130]. The advantages of the comet assay 
compared with other genotoxicity assays include i) sensitivity to detect low 
levels of DNA damage [209]; 2) use of small number of cells per sample 
[210]; 3) automated analysis [211]; 4) completion of an experiment in 
relatively short time [212]; 5) relatively low cost [213]; and 6) application to 
all nucleated eukaryotic cells [214]. Due to the various advantages of 
comet assay, it has been applied in diverse studies [214] including in vivo 
genotoxicity testing [215]. In previous studies in which the effects of 
cigarette smoke condensate/cigarette smoke on DNA strand breaks were 
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investigated by the comet assay, the focus was only on SSBs [62, 138-
139]. DSBs are a more disruptive form of strand break compared with 
SSBs, since they can either lead to cell death or loss of genetic 
information if left unrepaired, or they may cause neoplastic progression if 
the repair process is compromised [128, 144]. Therefore, both single- and 
double-strand breaks were detected in this work (Chapters II). 
Furthermore, we employed state-of-the-art multispectral imaging 
flow cytometry to detect and visualize oxidative DNA damage in human 
cervical cancer cells (Chapter III). This work benefited from a 
sophisticated and yet undisputable visualizing approach to identify 
cigarette smoke-induced oxidative DNA damage. The oxidative DNA 
damage can be indirectly visualized with a microscope by immuno-
staining with anti-8-0HdG antibody. The ImageStream automatically and 
objectively acquires thousands of images to quantify a specific lesion in 
single population of cells more efficiently than regular flow cytometer, 
since the obtained information on the cells can be further expanded to 
measure various parameters .. 
Another strength of this work is the use of cell culture experiments 
(Chapters II and III). This experimental setting is suitable to understand 
the mechanistic effect of cigarette smoking under a controlled 
environment, allowing the results of these studies to be translated to in 
vivo models. This work also employed an ex vivo study (Chapter IV), 
which allows the results of such studies to be better translated to the 
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human disease. Such studies provide data as proof-of principle, which 
may serve as a building block toward developing early biomarkers in 
identifying high-risk population. 
2. VVeaknesses 
The main focus of this dissertation was to investigate the effect of 
cigarette smoke on DNA damage and repair in human cervical and vaginal 
cells mainly due to its role as a significant cofactor in association with 
high-risk HPV infection in cervical/vaginal carcinogenesis. However, there 
are many other forms of damage (i.e. DNA base bulky adducts, DNA 
cross links, etc.) that can potentially attribute to mutagenicity of those 
diseases. 
Chapter II and III investigate the role of cigarette smoke in HPV-
transfected cells using a standardized in vitro model [169] in cervical 
carcinogenesis. However, it could be beneficial to study HPV-negative 
normal cervical cells to address the role of HPV infection as either 
dependent or independent factor as well as to further investigate the 
possible effect of cigarette smoking (additive or synergistic) in association 
with HPV infection. It is noteworthy that several unsuccessful attempts 
were made to culture HPV-negative normal cervical cells. 
One of the limitations of Chapter III was the inability to investigate 
the role of p53 in DNA repair pathways. Our data demonstrated that the 
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level of oxidative stress induced by cigarette smoke condensate is higher 
in HPV-positive compared with HPV-negative cervical cancer cells, and 
that the removal of the damage takes place by p53-dependent and -
independent DNA repair pathways. It may be useful to confirm the results 
of activation, or lack thereof, of p53 protein expression in human cervical 
cancer cells by performing western blotting. 
Chapter IV investigated whether cigarette smoking, given the 
infection with high-risk HPV types, leads to detectable DNA damage in 
vaginal cells by employing the comet assay. One of the advantages of this 
study was to examine DNA integrity at a single-cell level. However, 
double-strand break detection might not be the only cigarette smoking 
induced damage in these cells. The study may very well benefit from 
detection of other biological endpoints, such as single-strand breaks, 
oxidative DNA damage, bulky DNA adducts, etc. It is worth noting that 
remaining vaginal samples were preserved in formalin for future studies. 
One of the limitations in researching the association of smoking with HPV 
infection (Chapter IV) is a lack of information on the duration and intensity 
of smoking for the study population. The smoking information used in this 
study was based on self reporting. The association between self reporting 
and biochemical validation is approximately 85% [207] and could 
potentially influence the data interpretation. These data could contribute to 
further establish a correlation of the factors investigated. Another limitation 
is that the presented HPV data was based on the detection of the 
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collective presence of carcinogenic HPV types instead of providing 
information on the individual HPV genotypes. Therefore, it may be useful 
to determine specific HPV genotypes in order to provide further insights 
into the complex interrelation of smoking and HPV infection in vaginal 
carcinogenesis. 
c. Future Directions 
Future directions described herein are intended to address issues 
stated in Weaknesses (Chapter V). The rationale behind these proposed 
experiments is to strengthen the findings of this dissertation, although 
these future projects are independent of the completion of this 
dissertation. 
1. Does cigarette smoke induce other forms of damage in human 
cervical cancer cells? 
Cigarette smoke-induced genotoxicity results in induction of 
micronuclei, sister chromatid exchange, chromosomal aberrations, 
microsatellite instability, DNA strand breaks [58] and oxidative DNA 
damage [75, 165]. It has been well established that cigarette smoke 
accounts for a significant risk factor in developing cancer of various 
organs [42], including those of the cervix [43-44]. However, a mechanistic 
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approach to investigate other forms of damage caused by cigarette smoke 
in cervical cells has not been pursued. Therefore, a future study could 
investigate the effect of cigarette smoke in those cells and establish a 
correlation with HPV infection to broaden the knowledge in cervical 
carcinogenesis. 
2. Does cigarette smoking and/or HPV infection induce oxidative 
damage in vaginal cells? 
Cigarette smoke has been shown to cause a variety of oxidative 
DNA damage, including the formation of 8-oxodG [119-120]. 8-oxodG is a 
common mutagenic DNA lesion which is formed abundantly by 
intracellular oxidation and exogenous carcinogens like cigarette smoke 
[86, 121]. Mentioned previously, cell blocks of the collected human vaginal 
samples were also prepared at the time of sample processing. These 
samples can be used to investigate 8-oxodG expression by 
immunohistochemistry method. This information further adds to the scarce 
body of knowledge on the effect of cigarette smoking in vaginal cells. 
D. Significance of this Study 
As mentioned throughout this dissertation, cigarette smoking 
accounts as a significant cofactor in cervical/vaginal carcinogenesis. The 
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significance of the study in Chapter II stems from the fact that DNA lesions 
and/or persistent DNA strand breaks caused by the inability of the cells to 
remove the damage, may result in accumulation of mutations leading to 
cancer [89]. 
In Chapter 1111 of this dissertation, the detection of oxidative DNA 
damage and its repair in human cervical cancer cells by multispectral 
imaging flow cytometry analysis was reported. The detection and 
visualization of oxidative DNA damage in human cervical cancer cells are 
novel findings of this study, which may serve as early biomarkers of 
cancer. This is the first demonstration indicating higher degree of 8-oxodG 
by cigarette smoke constituents in HPV-positive compared to -negative 
human cervical cells. 
To date, there are no other studies that assess a biological 
endpoint such as DNA strand breaks in vaginal cells in relation to smoking 
and HPV infection status (Chapter IV). This finding builds on the limited 




E. Final notes 
There are number of factors associated with carcinogenic HPV 
infection of the cervix and vagina that have been implicated in 
development and progression of cervical/vaginal cancers. Cigarette 
smoking represents the strongest cofactor [66]. However, in depth 
experimental investigation is needed to link the numerous epidemiological 
findings as well as to understand the molecular mechanisms of high-risk 
HPV-associated vaginal cancer. Indeed, it is not yet clear if all vaginal 
cancers can be attributed to cofactors such as cigarette smoking in 
association with oncogenic HPV infection. Finally, the exact mechanism 
by which cigarette smoke mediates carcinogenesis could provide 
prophylactic and therapeutic applications that could ultimately be 


















(AU) Status Status 
~ ____ L-____ ~ ____ L-__ ~ 
Alkaline Neutral 
VG-60 Never Pas Undef. Undef. 38.01 3.79 
VG-61 Ever Neg 51 .29 9.07 71.88 10.63 
VG-62 Never Neg 49.44 6.49 87.43 13.69 
VG-63 NA NA Undef. Undef. Undef. Undef. 
VG-64 Ever Neg 56.33 9.03 63.82 8.13 
VG-65 Never Neg Undef. Undef. 42.89 4.82 
VG-67 Ever Neg Undef. Undef. 39.59 3.55 
VG-68 Ever Neg Undef. Undef. 49.82 3.24 
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VG-70 Ever Neg 
VG-71 NA NA 
VG-72 Ever Pas 
VG-73 NA NA 
VG-74 NA NA 
VG-75 NA NA 
VG-76 NA NA 
VG-77 Ever Neg 
VG-78 Never Neg 
VG-79 Never Pas 
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Mean Mean Mean Mean 
SM HPV TL TM TL TM 
Rep. Comet Rep. Comet 
10# Status Status (~m) (AU) (~m) (AU) Image Image 
Alkaline Neutral 
Alkaline Neutral 
VG-81 Never Pas 55.11 9.91 73.53 12.91 
VG-82 Never Pas 62.12 11 .17 72.13 12.01 
VG-83 Ever Neg 43.00 7.25 76.05 14.34 
VG-84 Never Neg 77.62 17.77 86.74 15.01 
VG-85 Never Neg 53.86 8.70 60.49 9.92 
VG-86 NA NA Undef. Undef. Undef. Undef. 
VG-87 Never Neg 55.38 10.02 67.21 7.43 
VG-88 Ever Neg Undef. Undef. 59.56 6.64 
VG-89 Ever Neg 47.25 8.29 64.80 8.28 
VG-90 NA NA Undef. Undef. Undef. Undef. 
VG-91 NA NA Undef. Undef. Undef. Undef. 
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Mean Mean Mean Mean 
Rep. Comet Rep. Comet 
SM HPV TL TM TL TM 
10# 




VG-92 Ever Neg 67.73 16.98 76.35 10.94 
VG-93 Never Neg Undef. Undef. 16.64 0.19 
VG-94 Never Neg 66.94 15.59 74.94 12.98 
VG-95 Never Neg 55.45 10.66 72.81 13.81 
VG-96 NA NA Undef. Undef. Undef. Undef. 
VG-97 NA NA Undef. Undef. Undef. Undef. 
VG-98 Never Neg 62.98 10.63 83.49 15.44 
VG-99 Ever Neg Undef. Undef. 77.26 8.21 
VG-100 Never Neg 
50.08 11.60 56.71 5.62 
VG-101 NA NA Undef. Undef. Undef. Undef. 
VG-102 Never Neg 49.67 10.83 65.33 10.05 
VG-103 Ever Neg 48.65 11.51 61 .86 9.10 
VG-104 Ever Neg Undef. Undef. 14.18 0.23 
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Mean Mean Mean Mean 
Rep. Comet 
SM HPV TL TM TL TM Rep. Comet 10# 
Status Status (~m) (AU) (~m) (AU) Image Image 
Alkaline Neutral 
Alkaline Neutral 
VG-105 Ever Neg 63.00 11.39 70.34 9.87 
VG-106 Never Neg 60.34 12.41 57.27 8.41 
VG-107 Ever Neg Undef. Undef. 17.45 0.85 
VG-108 Ever Neg 61 .11 13.73 60.68 8.29 
VG-109 NA NA Undef. Undef. Undef. Undef. 
VG-110 Ever Neg 65.93 13.86 74.91 9.67 
VG-111 Never Pas Undef. Undef. 22.47 0.92 
VG-112 NA NA Undef. Undef. Undef. Undef. 
VG-113 Ever Pas Undef. Undef. 13.03 0.45 
VG-114 Ever Pas Undef. Undef. 15.57 0.41 
VG-115 NA NA Undef. Undef. Undef. Undef. 
VG-116 Ever Pas Undef. Undef. 46.19 1.99 
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Mean Mean Mean Mean 
Rep. Comet 
SM HPV TL TM TL TM 
Rep. Comet 
10# 
Status Status (J.lm) (AU) (J.lm) (AU) Image Image 
Alkaline Neutral 
Alkaline Neutral 
VG-117 Ever Pes Undef. Undef. 16.44 1.03 
VG-118 Never Pes Undef. Undef. 34.74 4.00 
VG-119 Ever Pes Undef. Undef. 29.91 1.70 
VG-120 Ever Pes Undef. Undef. 17.98 1.47 
VG-121 NA NA Undef. Undef. Undef. Undef. 
VG-122 Ever Pes Undef. Undef. 25.91 2.04 
VG-123 Ever Pes Undef. Undef. 35.73 1.24 
VG-124 Never Pes Undef. Undef. 40.28 2.56 
VG-125 Ever Pes 43.19 8.30 35.08 1.76 
VG-126 Ever Pes Undef. Undef. 25.79 1.84 
VG-127 NA NA Undef. Undef. Undef. Undef. 
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Mean Mean Mean Mean 
Rep. Comet 
SM HPV TL TM TL TM 
Rep. Comet 
10# Status Status (IJm) (AU) (IJm) (AU) Image Image 
Alkaline Neutral 
Alkaline Neutral 
VG-128 Ever Pas Undef. Undef. 16.55 1.03 
VG-129 Ever Pas Undef. Undef. 45.83 2.45 
VG-130 Never Pas Undef. Undef. 42.92 2.41 
VG-131 Never Pas Undef. Undef. 29.49 1.65 
VG-132 Ever Pas Undef. Undef. 20.29 1.08 
VG-133 Never Pas Undef. Undef. 51.52 4.96 NA 
VG-134 Ever Pas Undef. Undef. 15.50 0.77 NA 
Ever Pas Undef. Undef. 12.87 0.23 NA 
Ever Pas Undef. Undef. 28.18 3.97 NA 
Pas Undef. Undef. 54.71 2.71 NA 
Ever Pas Undef. Undef. 46.46 3.01 NA 
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Mean Mean Mean Mean 
SM HPV TL TM TL TM 
Rep. Comet Rep. Comet 
10# Status Status (!.1m) (AU) (!.1m) (AU) Image Image 
Alkaline Neutral 
Alkaline Neutral 
VG-141 Ever Pas Undef. Undef. 13.09 0.31 NA 
VG-1 Ever Pas Undef. Undef. 16.15 0.66 NA 
VG-1 Never Pas Undef. Undef. 15.83 0.71 NA 
VG-1 Ever Pas Undef. Undef. 17.69 0.64 NA 
VG-1 Ever Pas Undef. Undef. 19.82 1.58 NA 
VG-1 NA NA Undef. Undef. Undef. Undef. NA 
VG-147 Never Pas Undef. Undef. 39.95 1.77 NA 
VG-148 Ever Pas Undef. Undef. 18.54 0.49 NA 
VG-149 Ever Pas Undef. Undef. 20.11 1.27 NA 
VG-150 Ever Pas Undef. Undef. 15.64 0.40 NA 
VG-151 Ever Pas Undef. Undef. 17.85 0.95 NA 
VG-152 Ever Pas Undef. Undef. 15.44 0.89 NA 
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Mean Mean Mean Mean 
SM HPV TL TM TL TM 










TL: tail length 
TM: tail moment 
AU: arbitrary unit 
NA: not available 
SM: smoking 
Alkaline Neutral 
Pes Undef. Undef. 22.57 0.84 
Pes Undef. Undef. 22.57 0.84 
Pes Undef. Undef. 14.91 0.34 
NA Undef. Undef. Undef. Undef. 
Pes Undef. Undef. 32.15 2.44 
NA Undef. Undef. Undef. Undef. 
Pes Undef. Undef. 14.75 0.55 
Pes Undef. Undef. 24.31 1.75 
NA Undef. Undef. Undef. Undef. 
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HPV: Human Papillomavirus 
SSBa: Single-Strand Breaks 
DSBa: Double-Strand Breaks 
CSC: Cigarette Smoke Condensate 
LSIL: Low-grade Squamous Intraepithelial Lesion 
HSIL: High-grade Squamous Intraepithelial Lesion 
T -ZONE: Transformation Zone 
pRb: Retinoblastoma protein 
PAHa: Polycyclic Aromatic Hydrocarbons 
NNK: nitrosamine 4-(methylnitrosamino )-1-(3-pyridyl)-1-butanone 
BP: benzo[a]pyrene 
ROS: Reactive Oxygen Species 
8-oxodG: 8-oxo-7 ,8-dihydro-2' -deoxyguanosine 
BER: Base Excision Repair 
SCGE: Single Cell Gel Electrophoresis 
TL: Tail Length 
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